1 |
(-)-trans-delta-9-tetrahydrocannabinol |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
2 |
(im) avonex® |
- |
- |
- |
- |
013 [1] 13 💬 |
3 |
(r) 3-(5-dimethylcarbamoyl-pent-1-enyl)-n-(2-hydroxy-1- methylethyl) benzamide |
- |
- |
- |
- |
013 [1] 13 💬 |
4 |
0,5 mg fingolimod |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
5 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
6 |
0.25mg rpc1063 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
7 |
0.5 mg rpc1063 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
8 |
0.5mg rpc1063 |
- |
- |
- |
- |
013 [1] 13 💬 |
9 |
1 - andrographis paniculata p/st extract |
- |
- |
- |
- |
013 [1] 13 💬 |
10 |
1 mg rpc1063 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
11 |
1% steroid cream |
- |
- |
- |
- |
013 [1] 13 💬 |
12 |
1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1h-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone |
- |
- |
- |
- |
013 [1] 13 💬 |
13 |
1.0mg rpc1063 |
- |
- |
- |
- |
013 [1] 13 💬 |
14 |
10 milligram (mg) fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
15 |
10000iu vitamin d |
Vitamin D |
- |
- |
- |
013 [1] 13 💬 |
16 |
11c-acetate |
Acetate |
- |
- |
- |
013 [3] 13, 86, 88 💬 |
17 |
11c-pbr28 |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
18 |
11c-pib |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
19 |
13-pcv booster |
- |
- |
- |
- |
013 [1] 13 💬 |
20 |
13-valent pneumococcal conjugate vaccine (13-pcv) |
- |
- |
- |
- |
013 [1] 13 💬 |
21 |
1393641-34-3 |
- |
- |
- |
- |
013 [1] 13 💬 |
22 |
15 mg fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
23 |
18f-dpa-714 and 18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
013 [1] 13 💬 |
24 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 [12] 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
25 |
18f-pm-pbb3 |
- |
- |
- |
- |
013 [1] 13 💬 |
26 |
19 nor vitamin d |
Vitamin D |
- |
- |
- |
013 [1] 13 💬 |
27 |
2 - excipients |
- |
- |
- |
- |
013 [1] 13 💬 |
28 |
2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester |
- |
- |
- |
- |
013 [1] 13 💬 |
29 |
2-cda |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
30 |
2-cda, 2-chloro-2'-deoxy-beta-d-adenosine |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
31 |
2-cda, 2-chloro-2'-deoxy-ß-d-adenosine |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
32 |
2-cda, 2-chloro-2?-deoxy-beta-d-adenosine |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
33 |
2-cda, 2-chloro-2?-deoxy-ß-d-adenosine |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
34 |
2-cda, 2-chloro-2’-deoxy-beta-d-adenosine |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
35 |
2-cda, 2-chloro-2’-deoxy-ß-d-adenosine |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
36 |
2-chloro-2'-deoxy-beta-d-adenosine (2-cda) |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
37 |
2-chloro-2'-deoxy-ß-d-adenosine (2-cda) |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
38 |
2-chloro-2'-deoxyadenosine (2-cda) |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
39 |
2-chloro-2'-deoxyadenosine, 2cda |
- |
- |
- |
- |
013 [1] 13 💬 |
40 |
2-chloro-2?-deoxy-beta-d-adenosine |
Adenosine |
[1] D00045 D00045 💬 |
ADORA1 [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
41 |
2-chloro-2?-deoxy-ß-d-adenosine |
Adenosine |
[1] D00045 D00045 💬 |
ADORA1 [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
42 |
2-chloro-2’-deoxy-beta-d-adenosine |
Adenosine |
[1] D00045 D00045 💬 |
ADORA1 [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
43 |
2-chloro-2’-deoxy-beta-d-adenosine (2-cda) |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
44 |
2-chloro-2’-deoxy-ß-d-adenosine |
Adenosine |
[1] D00045 D00045 💬 |
ADORA1 [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
45 |
2-chloro-2’-deoxy-ß-d-adenosine (2-cda) |
Adenosine |
[2] D00045 D00045, D01370 D01370 💬 |
ADORA1 [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
46 |
2-chloro-2’-deoxyadenosine (2-cda) |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
47 |
20 mg fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
48 |
20 mg ga |
- |
- |
- |
- |
013 [1] 13 💬 |
49 |
20 mg mitoq |
- |
- |
- |
- |
013 [1] 13 💬 |
50 |
200106 or emd 28162 |
- |
- |
- |
- |
013 [1] 13 💬 |
51 |
20mg/0.5ml ga |
- |
- |
- |
- |
013 [1] 13 💬 |
52 |
20mg/0.5ml glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
53 |
23-ppv |
- |
- |
- |
- |
013 [1] 13 💬 |
54 |
23-valent pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
013 [3] 13, 46, 53 💬 |
55 |
23-valent pneumococcal polysaccharide vaccine (23-ppv) |
- |
- |
- |
- |
013 [1] 13 💬 |
56 |
25oh-vitamin d |
Vitamin D |
- |
- |
- |
013 [1] 13 💬 |
57 |
2b3-201 |
- |
- |
- |
- |
013 [1] 13 💬 |
58 |
3 mg melatonin |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
59 |
3,4-diaminopyridine |
- |
- |
- |
- |
011 [3] 11, 12, 13 💬 |
60 |
4-aminopyridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 [2] 3 , 13 💬 |
61 |
4-ap |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
62 |
4.5 mg naltrexone |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
63 |
40 mg ga |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
64 |
40 mg glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 [2] 2 , 13 💬 |
65 |
40 mg glatiramer acetato |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
66 |
40mg of mitoq |
- |
- |
- |
- |
013 [1] 13 💬 |
67 |
5 mg melatonin |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
68 |
5000iu vitamin d |
Vitamin D |
- |
- |
- |
013 [1] 13 💬 |
69 |
52069.00.01 |
- |
- |
- |
- |
013 [1] 13 💬 |
70 |
9060x |
- |
- |
- |
- |
013 [2] 13, 149 💬 |
71 |
95% pure ecgc capsules 200mg |
- |
- |
- |
- |
013 [1] 13 💬 |
72 |
[11c]flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 [1] 13 💬 |
73 |
[123i]clinde |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
74 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
75 |
[18f] pbr06 |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
76 |
[18f]-feppa |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
77 |
[18f]dpa-714 |
- |
- |
- |
- |
013 [1] 13 💬 |
78 |
[18f]florbetapir and pet imaging |
- |
- |
- |
- |
013 [1] 13 💬 |
79 |
[c-11]methylreboxetine |
- |
- |
- |
- |
013 [1] 13 💬 |
80 |
[c-11]pbr28 |
- |
- |
- |
- |
013 [1] 13 💬 |
81 |
[c11]pk-1195 pet scan |
- |
- |
- |
- |
013 [1] 13 💬 |
82 |
[f-18]pbr06 |
- |
- |
- |
- |
013 [2] 13, 17 💬 |
83 |
[f-18]sdm-8 |
- |
- |
- |
- |
013 [1] 13 💬 |
84 |
[formistin 10 mg] |
- |
- |
- |
- |
013 [1] 13 💬 |
85 |
[md1003] |
- |
- |
- |
- |
013 [1] 13 💬 |
86 |
[metilprednisolone] |
- |
- |
- |
- |
013 [1] 13 💬 |
87 |
[omb157] |
- |
- |
- |
- |
013 [1] 13 💬 |
88 |
[tachipirina cpr 500mg] |
- |
- |
- |
- |
013 [1] 13 💬 |
89 |
[zr-89]oxine-labeled leukocytes pet/mr |
Oxyquinoline |
[1] D05321 D05321 💬 |
- |
- |
013 [1] 13 💬 |
90 |
A4i antagonist |
- |
- |
- |
- |
013 [1] 13 💬 |
91 |
Ab1010 |
- |
- |
- |
- |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
92 |
Abatacept |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
93 |
Abobotulinumtoxin a |
- |
- |
- |
- |
013 [1] 13 💬 |
94 |
Abr-215062 |
- |
- |
- |
- |
013 [1] 13 💬 |
95 |
Abr-215062 sodium salt |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
96 |
Abt-555 |
- |
- |
- |
- |
013 [1] 13 💬 |
97 |
Abt-874/human monoclonal antibody against il-12 |
- |
- |
- |
- |
013 [1] 13 💬 |
98 |
Abx-1431 |
ABX-1431 |
- |
- |
- |
013 [1] 13 💬 |
99 |
Abx-1431 hcl |
ABX-1431 |
- |
- |
- |
013 [1] 13 💬 |
100 |
Acetaminophen |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 [14] 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
101 |
Acetaminophen tab 650mg |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
102 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
103 |
Acetazolamide |
Acetazolamide |
[2] D00218 D00218, D01196 D01196 💬 |
CA1 [13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion [7] Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
013 [6] 13, 90, 115, 155, 225, 230 💬 |
104 |
Acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [16] 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
105 |
Acetylsalicylic acid |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [4] 13, 46, 51, 210 💬 |
106 |
Acetylsalicylic acid at 1st visit, |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
107 |
Aciclovir |
Acyclovir |
[1] D00222 D00222 💬 |
- |
- |
013 [2] 13, 60 💬 |
108 |
Aclasta |
- |
- |
- |
- |
013 [3] 13, 271, 274 💬 |
109 |
Aclasta 5 mg infusionslösung |
- |
- |
- |
- |
013 [1] 13 💬 |
110 |
Aclasta 5mg solution for infusion |
- |
- |
- |
- |
013 [1] 13 💬 |
111 |
Act |
- |
- |
- |
- |
013 [1] 13 💬 |
112 |
Act-1 |
- |
- |
- |
- |
013 [1] 13 💬 |
113 |
Act-128800 |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
114 |
Act-128800 dose 1 |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
115 |
Act-128800 dose 2 |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
116 |
Act-128800 dose 3 |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
117 |
Acth |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [5] 13, 66, 145, 193, 222 💬 |
118 |
Acthar |
- |
- |
- |
- |
002 [9] 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
119 |
Acthar gel |
- |
- |
- |
- |
013 [6] 13, 46, 49, 50, 84, 222 💬 |
120 |
Acthar gel (acth) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [1] 13 💬 |
121 |
Active comparator receiving extavia® |
- |
- |
- |
- |
013 [1] 13 💬 |
122 |
Active control |
- |
- |
- |
- |
013 [1] 13 💬 |
123 |
Actos (pioglitazone) |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
013 [1] 13 💬 |
124 |
Acyclovir |
Acyclovir |
[1] D00222 D00222 💬 |
- |
- |
013 [2] 13, 28 💬 |
125 |
Adderall xr |
- |
- |
- |
- |
013 [1] 13 💬 |
126 |
Adderall xr 10 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
127 |
Adderall xr 5mg |
- |
- |
- |
- |
013 [1] 13 💬 |
128 |
Adenosine |
Adenosine |
[1] D00045 D00045 💬 |
ADORA1 [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [3] 13, 58, 65 💬 |
129 |
Adrenocorticotropic hormone |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [3] 13, 50, 84 💬 |
130 |
Adrenocorticotropic hormone (acth) gel (h.p. acthar®) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [1] 13 💬 |
131 |
Ads-5102 |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
132 |
Ads-5102, 137 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
133 |
Ads-5102, 274 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
134 |
Aert, (r)-baclofen |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
135 |
Agee cream |
- |
- |
- |
- |
013 [1] 13 💬 |
136 |
Ahsc |
- |
- |
- |
- |
013 [1] 13 💬 |
137 |
Aimspro |
- |
- |
- |
- |
013 [2] 13, 51 💬 |
138 |
Ain |
- |
- |
- |
- |
013 [1] 13 💬 |
139 |
Ain457 |
- |
- |
- |
- |
013 [7] 13, 37, 41, 46, 56, 96, 271 💬 |
140 |
Alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
006 [4] 6 , 13, 298, 299 💬 |
141 |
Albumin (human) 25%, united states pharmacopeia (usp) |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
142 |
Albuterol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 [8] 12, 13, 86, 89, 113, 231, 256, 299 💬 |
143 |
Alcohol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 [4] 13, 58, 279, 298 💬 |
144 |
Alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [16] 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
145 |
Alemtuzumab (gz402673) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
146 |
Alemtuzumab 12 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
147 |
Alemtuzumab 24 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
148 |
Alemtuzumab gz402673 |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
149 |
Alemtuzumab immunotherapy |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
150 |
Alemtuzumab injection |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
151 |
Alemtuzumab injection [lemtrada] |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
152 |
Alfuzosin |
Alfuzosin |
[2] D01692 D01692, D07124 D07124 💬 |
ADRA1A [1] ADRA1A 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
153 |
Alks 8700 |
- |
- |
- |
- |
013 [1] 13 💬 |
154 |
Alks 8700 delayed release (dr) |
- |
- |
- |
- |
013 [1] 13 💬 |
155 |
Alks 8700 delayed release (dr) capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
156 |
Allogeneic fecal microbiota |
- |
- |
- |
- |
013 [1] 13 💬 |
157 |
Allogeneic human umbilical cord tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
158 |
Alpha lipoic acid |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
013 [1] 13 💬 |
159 |
Alpha-lipoic acid |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
002 [2] 2 , 13 💬 |
160 |
Alpha1-antitrypsin |
- |
- |
- |
- |
013 [1] 13 💬 |
161 |
Altri farmaci del sistema nervoso |
- |
- |
- |
- |
013 [1] 13 💬 |
162 |
Alxn1210 |
- |
- |
- |
- |
002 [5] 2 , 11, 13, 62, 109 💬 |
163 |
Amantadine |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [4] 6 , 8 , 13, 127 💬 |
164 |
American ginseng |
Ginseng |
[1] D06772 D06772 💬 |
- |
- |
013 [1] 13 💬 |
165 |
American ginseng extract ht-1001 |
Ginseng |
[1] D06772 D06772 💬 |
- |
- |
013 [1] 13 💬 |
166 |
Amiloride |
Amiloride |
[2] D00649 D00649, D07447 D07447 💬 |
SCNN1A [3] SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption [2] Aldosterone-regulated sodium reabsorption, Taste transduction |
013 [3] 13, 225, 299 💬 |
167 |
Amiloride hydrochloride |
Amiloride |
[2] D00649 D00649, D07447 D07447 💬 |
SCNN1A [3] SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption [2] Aldosterone-regulated sodium reabsorption, Taste transduction |
013 [1] 13 💬 |
168 |
Amiloride hydrochloride, 2 h2o |
Amiloride |
[2] D00649 D00649, D07447 D07447 💬 |
SCNN1A [3] SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption [2] Aldosterone-regulated sodium reabsorption, Taste transduction |
013 [1] 13 💬 |
169 |
Amilostad |
- |
- |
- |
- |
013 [1] 13 💬 |
170 |
Amilostad hct |
- |
- |
- |
- |
013 [1] 13 💬 |
171 |
Amilostad hct tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
172 |
Ampyra |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
173 |
Amyvid |
- |
- |
- |
- |
013 [2] 13, 127 💬 |
174 |
Amyvid radiopharmaceutical |
- |
- |
- |
- |
013 [1] 13 💬 |
175 |
An100226 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
176 |
An100226, bg00002 |
- |
- |
- |
- |
013 [1] 13 💬 |
177 |
Anakinra |
Anakinra |
[1] D02934 D02934 💬 |
IL1R1 [2] IL1R1, IL1R2 💬 |
Amoebiasis [15] Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 [17] 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
178 |
Androgel 1 % topical gel |
- |
- |
- |
- |
013 [1] 13 💬 |
179 |
Androgel 10 grams of gel containing 100 mg of testosterone |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 [1] 13 💬 |
180 |
Andrographolides |
- |
- |
- |
- |
013 [1] 13 💬 |
181 |
Anesthetic topical adhesive synera |
- |
- |
- |
- |
013 [1] 13 💬 |
182 |
Ank-700 |
- |
- |
- |
- |
013 [1] 13 💬 |
183 |
Anti lp40 antibody, subclass igg4 la294 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
184 |
Anti-cd25 humanized monoclonal antibody |
- |
- |
- |
- |
013 [1] 13 💬 |
185 |
Anti-cd52 monoclonal antibody |
- |
- |
- |
- |
013 [1] 13 💬 |
186 |
Anti-il-12 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
187 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 [18] 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
188 |
Anticholinergic medication |
- |
- |
- |
- |
013 [1] 13 💬 |
189 |
Anticuerpo monoclonal anti-lingo-1 humano |
- |
- |
- |
- |
013 [1] 13 💬 |
190 |
Antihistamine |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
191 |
Antimycotic |
- |
- |
- |
- |
013 [1] 13 💬 |
192 |
Antithymocyte |
- |
- |
- |
- |
013 [1] 13 💬 |
193 |
Antithymocyte gamma immunoglobulin |
- |
- |
- |
- |
013 [1] 13 💬 |
194 |
Antithymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
195 |
Antithymocyte immunoglobulin (rabbit) |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
196 |
Anxiety/depression and work and activities |
- |
- |
- |
- |
013 [1] 13 💬 |
197 |
Ap |
- |
- |
- |
- |
002 [4] 2 , 6 , 13, 299 💬 |
198 |
Apitox - pure honeybee toxin |
- |
- |
- |
- |
013 [1] 13 💬 |
199 |
Arbaclofen |
Arbaclofen |
[1] D09791 D09791 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [2] 13, 206 💬 |
200 |
Arbaclofen er tablets |
Arbaclofen |
[1] D09791 D09791 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
201 |
Arbaclofen extended release tablets |
Arbaclofen |
[1] D09791 D09791 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
202 |
Arbaclofen placarbil |
Arbaclofen |
[2] D08861 D08861, D09791 D09791 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
203 |
Arbaclofen placarbil 15 mg bid |
Arbaclofen |
[2] D08861 D08861, D09791 D09791 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
204 |
Arbaclofen placarbil 30 mg bid |
Arbaclofen |
[2] D08861 D08861, D09791 D09791 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
205 |
Arbaclofen placarbil 45 mg bid |
Arbaclofen |
[2] D08861 D08861, D09791 D09791 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
206 |
Aricept |
- |
- |
- |
- |
006 [4] 6 , 13, 78, 124 💬 |
207 |
Aricept 10 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
208 |
Aricept 10 mg filmdragerade tabletter |
- |
- |
- |
- |
013 [1] 13 💬 |
209 |
Aricept 5 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
210 |
Aricept 5 mg filmdragerade tabletter |
- |
- |
- |
- |
013 [1] 13 💬 |
211 |
Arm 1 - geh120714 (18f) injection |
- |
- |
- |
- |
013 [1] 13 💬 |
212 |
Armodafinil |
Armodafinil |
[1] D03215 D03215 💬 |
SLC6A3 [1] SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [3] 6 , 13, 84 💬 |
213 |
Arn-6039 |
- |
- |
- |
- |
013 [1] 13 💬 |
214 |
Arzerra |
- |
- |
- |
- |
013 [1] 13 💬 |
215 |
Arzerra® |
- |
- |
- |
- |
013 [1] 13 💬 |
216 |
Asa |
- |
- |
- |
- |
013 [4] 13, 96, 97, 251 💬 |
217 |
Asb-683699 |
- |
- |
- |
- |
013 [1] 13 💬 |
218 |
Aspirin |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [11] 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
219 |
Aspirin 650mg oral capsule |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
220 |
Ata188 |
- |
- |
- |
- |
013 [1] 13 💬 |
221 |
Atacicept |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [4] 13, 46, 49, 66 💬 |
222 |
Atacicept 150 mg |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [2] 13, 49 💬 |
223 |
Atacicept 25 mg |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [2] 13, 66 💬 |
224 |
Atacicept 75 mg |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [3] 13, 49, 66 💬 |
225 |
Atg |
- |
- |
- |
- |
013 [4] 13, 60, 96, 285 💬 |
226 |
Atl1102 |
ATL1102 |
- |
- |
- |
013 [1] 13 💬 |
227 |
Atomoxetine |
Atomoxetine |
[2] D02574 D02574, D07473 D07473 💬 |
SLC6A2 [1] SLC6A2 💬 |
Synaptic vesicle cycle [1] Synaptic vesicle cycle |
006 [3] 6 , 8 , 13 💬 |
228 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
229 |
Atx-ms-1467 |
- |
- |
- |
- |
013 [1] 13 💬 |
230 |
Aubagio |
- |
- |
- |
- |
013 [1] 13 💬 |
231 |
Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse |
- |
- |
- |
- |
013 [1] 13 💬 |
232 |
Aubagio® |
- |
- |
- |
- |
013 [1] 13 💬 |
233 |
Autologous adipose derived mesenchymal cells |
- |
- |
- |
- |
013 [1] 13 💬 |
234 |
Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved |
- |
- |
- |
- |
013 [1] 13 💬 |
235 |
Autologous bone marrow-derived mononuclear stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
236 |
Autologous cd4+t cells stimulated and expanded ex vivo by a mog peptide modified by the introduction of a thioreductase motif into the flanking residues of the t cell epitope |
- |
- |
- |
- |
013 [1] 13 💬 |
237 |
Autologous hematopoietic stem cell |
- |
- |
- |
- |
013 [1] 13 💬 |
238 |
Autologous hematopoietic stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
239 |
Autologous mesenchymal cell product |
- |
- |
- |
- |
013 [1] 13 💬 |
240 |
Autologous mesenchymal stem cell transplantation |
- |
- |
- |
- |
013 [1] 13 💬 |
241 |
Autologous mesenchymal stem cells |
- |
- |
- |
- |
002 [5] 2 , 6 , 13, 17, 46 💬 |
242 |
Autologous stem cells |
- |
- |
- |
- |
013 [2] 13, 51 💬 |
243 |
Autologous t-lymphocytes |
- |
- |
- |
- |
013 [1] 13 💬 |
244 |
Autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (toldc-vitd3) |
- |
- |
- |
- |
013 [1] 13 💬 |
245 |
Av605 |
- |
- |
- |
- |
013 [1] 13 💬 |
246 |
Avonex |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
247 |
Avonex (interferon beta 1a) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
248 |
Avonex (interferon beta-1a), biogen idec ltd |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
249 |
Avonex 30 microgram/0.5 ml solution for injection |
- |
- |
- |
- |
013 [1] 13 💬 |
250 |
Avonex 30 microgramos/0,5 ml (interferón beta - 1a) solución inyectable |
- |
- |
- |
- |
013 [1] 13 💬 |
251 |
Avonex 30 microgramos/0.5 ml solución para inyección |
- |
- |
- |
- |
013 [1] 13 💬 |
252 |
Avonex 30 µg/0,5 ml solution for injection |
- |
- |
- |
- |
013 [1] 13 💬 |
253 |
Avonex and topamax |
- |
- |
- |
- |
013 [1] 13 💬 |
254 |
Avonex im 4sir 30mcg/0,5ml 4ag |
- |
- |
- |
- |
013 [1] 13 💬 |
255 |
Avonex*im 4sir 30mcg/0,5ml+4ag |
- |
- |
- |
- |
013 [1] 13 💬 |
256 |
Avonex/betaseron/copaxone/rebif |
- |
- |
- |
- |
013 [1] 13 💬 |
257 |
Avonex/zocor |
- |
- |
- |
- |
013 [1] 13 💬 |
258 |
Avonex® |
- |
- |
- |
- |
013 [1] 13 💬 |
259 |
Avonex® monotherapy (6.0 miu administered i.m. each week) |
- |
- |
- |
- |
013 [1] 13 💬 |
260 |
Avp-923 |
- |
- |
- |
- |
002 [3] 2 , 6 , 13 💬 |
261 |
Azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
006 [20] 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
262 |
Azathioprine (aza) |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
013 [3] 13, 19, 97 💬 |
263 |
Azatioprina |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
013 [3] 13, 96, 97 💬 |
264 |
Azatioprina hex. 50cpr 50mg bl |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
013 [1] 13 💬 |
265 |
Azithromycin |
Azithromycin |
[3] D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 [6] 13, 84, 85, 96, 228, 299 💬 |
266 |
Bacille calmette-guerin vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
267 |
Bacille of calmette-guerin |
- |
- |
- |
- |
013 [1] 13 💬 |
268 |
Baclofen |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 [5] 2 , 10, 13, 18, 149 💬 |
269 |
Baclofen 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
270 |
Baclofen er capsules (grs) 10 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
271 |
Baclofen er capsules (grs) 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
272 |
Baclofen er capsules (grs) 30mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
273 |
Baclofen er capsules (grs) 40mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
274 |
Baclofen er capsules (grs) 50 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
275 |
Baclofen ir |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
276 |
Baclofen tablets usp |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
277 |
Baclofen tablets usp 10 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
278 |
Baf312 |
- |
- |
- |
- |
013 [2] 13, 50 💬 |
279 |
Baf312 0,25 mg tablet |
- |
- |
- |
- |
013 [1] 13 💬 |
280 |
Baf312 1 mg tablet |
- |
- |
- |
- |
013 [2] 13, 50 💬 |
281 |
Baf312 4 mg tablet |
- |
- |
- |
- |
013 [1] 13 💬 |
282 |
Baf312 hemifumarate |
- |
- |
- |
- |
013 [2] 13, 50 💬 |
283 |
Baf312a |
- |
- |
- |
- |
013 [1] 13 💬 |
284 |
Bafiertam |
- |
- |
- |
- |
013 [1] 13 💬 |
285 |
Balance |
Isoxaflutole |
- |
- |
- |
005 [9] 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
286 |
Baminercept |
Baminercept |
[1] D08866 D08866 💬 |
LTB [1] LTB 💬 |
Cytokine-cytokine receptor interaction [3] Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [4] 13, 46, 53, 97 💬 |
287 |
Baseline treatment |
- |
- |
- |
- |
013 [1] 13 💬 |
288 |
Bat4406f |
- |
- |
- |
- |
013 [1] 13 💬 |
289 |
Bay 79-4998 |
- |
- |
- |
- |
013 [1] 13 💬 |
290 |
Bay86-5046 |
- |
- |
- |
- |
013 [1] 13 💬 |
291 |
Bay86-5046_interferon-beta-1b |
- |
- |
- |
- |
013 [1] 13 💬 |
292 |
Bazedoxifene |
Bazedoxifene |
[1] D03062 D03062 💬 |
- |
- |
013 [1] 13 💬 |
293 |
Bazedoxifene acetate |
Acetate |
[1] D03062 D03062 💬 |
- |
- |
013 [1] 13 💬 |
294 |
Bbr 2778 |
- |
- |
- |
- |
011 [2] 11, 13 💬 |
295 |
Bcd-033 (interferon beta 1a) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
296 |
Bcd-054 180 mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
297 |
Bcd-054 240 mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
298 |
Bcd-063 |
- |
- |
- |
- |
013 [1] 13 💬 |
299 |
Bcd-132 |
- |
- |
- |
- |
013 [1] 13 💬 |
300 |
Bcd-132, 125 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
301 |
Bcd-132, 500 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
302 |
Bcg20-0134 |
- |
- |
- |
- |
013 [1] 13 💬 |
303 |
Beam regimen |
- |
- |
- |
- |
013 [1] 13 💬 |
304 |
Beetainterferoni -1a |
- |
- |
- |
- |
013 [1] 13 💬 |
305 |
Behavioral: 6 months weight resistance and balance program |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
306 |
Behavioral: adherence counseling |
- |
- |
- |
- |
013 [1] 13 💬 |
307 |
Behavioral: assessment of disability |
- |
- |
- |
- |
013 [1] 13 💬 |
308 |
Behavioral: assessment of impact of ms on cognition |
- |
- |
- |
- |
013 [1] 13 💬 |
309 |
Behavioral: balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
310 |
Behavioral: collaborative care (cc) |
- |
- |
- |
- |
013 [1] 13 💬 |
311 |
Behavioral: learning |
- |
- |
- |
- |
013 [1] 13 💬 |
312 |
Behavioral: medical marijuana |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
313 |
Behavioral: meditation |
- |
- |
- |
- |
013 [1] 13 💬 |
314 |
Behavioral: motivational interviewing |
- |
- |
- |
- |
013 [1] 13 💬 |
315 |
Behavioral: physical activity together for pwms and their cgs (pat-ms) |
- |
- |
- |
- |
013 [1] 13 💬 |
316 |
Behavioral: self massage |
- |
- |
- |
- |
013 [1] 13 💬 |
317 |
Behavioral: step tracking |
- |
- |
- |
- |
013 [1] 13 💬 |
318 |
Behavioral: telephone-based cognitive behavioral therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
319 |
Behavioral: water tracking |
Water |
[1] D00001 D00001 💬 |
- |
- |
013 [1] 13 💬 |
320 |
Best available therapy (bat) |
- |
- |
- |
- |
013 [1] 13 💬 |
321 |
Beta-1b interferoni |
- |
- |
- |
- |
013 [1] 13 💬 |
322 |
Beta-alanine |
Alanine |
[2] D00012 D00012, D07561 D07561 💬 |
- |
- |
013 [1] 13 💬 |
323 |
Beta-alanine supplementation |
Alanine |
[2] D00012 D00012, D07561 D07561 💬 |
- |
- |
013 [1] 13 💬 |
324 |
Beta-carotene |
Beta carotene |
[1] D03101 D03101 💬 |
- |
- |
013 [1] 13 💬 |
325 |
Beta-interferon |
- |
- |
- |
- |
013 [1] 13 💬 |
326 |
Betacarotene |
Beta carotene |
[1] D03101 D03101 💬 |
- |
- |
013 [1] 13 💬 |
327 |
Betaferon |
- |
- |
- |
- |
013 [1] 13 💬 |
328 |
Betaferon 250 mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
329 |
Betaferon 250 microgram/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
330 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection |
- |
- |
- |
- |
013 [1] 13 💬 |
331 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection. |
- |
- |
- |
- |
013 [1] 13 💬 |
332 |
Betaferon 250 microgramos |
- |
- |
- |
- |
013 [1] 13 💬 |
333 |
Betaferon 250mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
334 |
Betaferon 250µg |
- |
- |
- |
- |
013 [1] 13 💬 |
335 |
Betaferon 500 mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
336 |
Betaferon 500 µg |
- |
- |
- |
- |
013 [1] 13 💬 |
337 |
Betaferon 500mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
338 |
Betaferon 500µg |
- |
- |
- |
- |
013 [1] 13 💬 |
339 |
Betaferon sc 15f 0,25mg 15sir |
- |
- |
- |
- |
013 [1] 13 💬 |
340 |
Betaferon*15confez 0,25mg/ml+ |
- |
- |
- |
- |
013 [1] 13 💬 |
341 |
Betaferon, bay 86-5046 |
- |
- |
- |
- |
013 [1] 13 💬 |
342 |
Betaferon/betaseron |
- |
- |
- |
- |
013 [1] 13 💬 |
343 |
Betaferon® |
- |
- |
- |
- |
013 [1] 13 💬 |
344 |
Betaferon® (interferon beta-1b) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
345 |
Betaseron |
- |
- |
- |
- |
013 [1] 13 💬 |
346 |
Betaseron (interferon beta-1b, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
347 |
Betaseron (interferon beta-1b, bay86-5046), bayer healthcare ag |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
348 |
Bevacizumab |
Bevacizumab |
[1] D06409 D06409 💬 |
VEGFA [1] VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
013 [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬 |
349 |
Bexarotene |
Bexarotene |
[1] D03106 D03106 💬 |
RXRA [3] RXRA, RXRB, RXRG 💬 |
Adipocytokine signaling pathway [15] Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
013 [2] 13, 75 💬 |
350 |
Bg-12 120 |
- |
- |
- |
- |
013 [1] 13 💬 |
351 |
Bg00002 |
- |
- |
- |
- |
013 [1] 13 💬 |
352 |
Bg00002 (natalizumab) |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
353 |
Bg00002-e (natalizumab high titer) |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
354 |
Bg00012 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
355 |
Bg00012 (dmf) |
- |
- |
- |
- |
013 [1] 13 💬 |
356 |
Bg00012 (dmf) (tecfidera®.) |
- |
- |
- |
- |
013 [1] 13 💬 |
357 |
Bg0002 (natalizumab) |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
358 |
Bg9418 (interferon beta 1-a) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
359 |
Bg9418 (interferon beta-1a) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [2] 13, 97 💬 |
360 |
Bgc20-0134 |
- |
- |
- |
- |
013 [1] 13 💬 |
361 |
Bgg492 |
- |
- |
- |
- |
013 [1] 13 💬 |
362 |
Bht-3009 |
- |
- |
- |
- |
013 [1] 13 💬 |
363 |
Bht-3009 0.5 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
364 |
Bht-3009 1.5 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
365 |
Bht-3009-01 |
- |
- |
- |
- |
013 [1] 13 💬 |
366 |
Biib017 |
- |
- |
- |
- |
013 [1] 13 💬 |
367 |
Biib017 (peginterferon beta-1a) |
Peginterferon beta-1a |
[1] D10483 D10483 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
368 |
Biib019 |
- |
- |
- |
- |
013 [1] 13 💬 |
369 |
Biib019 (daclizumab high yield process) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
370 |
Biib019 (daclizumab) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
371 |
Biib033 |
- |
- |
- |
- |
013 [1] 13 💬 |
372 |
Biib033 (anti-lingo) |
- |
- |
- |
- |
013 [1] 13 💬 |
373 |
Biib033 (anti-lingo) - ev substance code sub118957 |
- |
- |
- |
- |
013 [1] 13 💬 |
374 |
Biib033 (opicinumab) |
Opicinumab |
[1] D11767 D11767 💬 |
- |
- |
013 [1] 13 💬 |
375 |
Biib041 |
- |
- |
- |
- |
013 [1] 13 💬 |
376 |
Biib041 (fampridine) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
377 |
Biib041 (fampridine-sr) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
378 |
Biib041 (pr fampridine) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
379 |
Biib061 |
- |
- |
- |
- |
013 [1] 13 💬 |
380 |
Biib133 |
- |
- |
- |
- |
013 [1] 13 💬 |
381 |
Biotin |
Biotin |
[1] D00029 D00029 💬 |
- |
- |
002 [5] 2 , 8 , 10, 13, 20 💬 |
382 |
Biotina |
Biotin |
[1] D00029 D00029 💬 |
- |
- |
013 [1] 13 💬 |
383 |
Birt 2584 xx |
- |
- |
- |
- |
013 [1] 13 💬 |
384 |
Birt 2584xx |
- |
- |
- |
- |
013 [1] 13 💬 |
385 |
Bisacodyl |
Bisacodyl |
[1] D00245 D00245 💬 |
- |
- |
013 [1] 13 💬 |
386 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
387 |
Blood samples |
- |
- |
- |
- |
013 [8] 13, 41, 46, 51, 61, 97, 227, 271 💬 |
388 |
Blood sampling |
- |
- |
- |
- |
013 [5] 13, 17, 19, 51, 96 💬 |
389 |
Bmmnc |
- |
- |
- |
- |
013 [1] 13 💬 |
390 |
Bms 188667 (abatacept) |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
013 [1] 13 💬 |
391 |
Bone marrow autologous mesenchymal stem cells transplantation |
- |
- |
- |
- |
013 [1] 13 💬 |
392 |
Borage oil |
Borage oil |
- |
- |
- |
013 [1] 13 💬 |
393 |
Borage oil 20% gla |
Borage oil |
- |
- |
- |
013 [1] 13 💬 |
394 |
Bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
395 |
Bosentan |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [11] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
396 |
Boswelan |
- |
- |
- |
- |
013 [1] 13 💬 |
397 |
Boswellia serrata |
Indian frankincense |
- |
- |
- |
013 [1] 13 💬 |
398 |
Boswellia serrata extract |
Indian frankincense |
- |
- |
- |
013 [1] 13 💬 |
399 |
Boswellia serrata extract ps0201bo capsules |
Indian frankincense |
- |
- |
- |
013 [1] 13 💬 |
400 |
Boswellic acids (boswelan) |
- |
- |
- |
- |
013 [1] 13 💬 |
401 |
Botox |
- |
- |
- |
- |
002 [6] 2 , 6 , 13, 51, 149, 226 💬 |
402 |
Botox® |
- |
- |
- |
- |
013 [1] 13 💬 |
403 |
Botulinum toxin |
- |
- |
- |
- |
006 [3] 6 , 13, 149 💬 |
404 |
Botulinum toxin a |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
013 [4] 13, 51, 149, 226 💬 |
405 |
Botulinum toxin a - haemagglutinin complex |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
013 [1] 13 💬 |
406 |
Botulinum toxin type a |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [10] 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
407 |
Botulinum toxin type a 200u |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
013 [1] 13 💬 |
408 |
Botulinum toxin type a 300u |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
013 [1] 13 💬 |
409 |
Botulinum toxin type a infiltrations |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
013 [1] 13 💬 |
410 |
Brimonidine |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [2] 13, 90 💬 |
411 |
Brimonidine tartrate |
Brimonidine |
[2] D02076 D02076, D07540 D07540 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [2] 13, 90 💬 |
412 |
Bx-1 |
- |
- |
- |
- |
013 [1] 13 💬 |
413 |
C1-esterase inhibitor (cinryze) |
- |
- |
- |
- |
013 [1] 13 💬 |
414 |
C105 |
- |
- |
- |
- |
013 [1] 13 💬 |
415 |
Caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [9] 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
416 |
Calcio |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
417 |
Calcio folinato dc.it |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
418 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
419 |
Calcium and vitamin d combination |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
420 |
Calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
013 [8] 13, 19, 46, 53, 75, 96, 235, 299 💬 |
421 |
Calcium levofolinate |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
422 |
Cannabidiol |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [17] 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
423 |
Cannabidiol / dronabinol capsule 5 mg+2,5 mg |
Cannabidiol |
[2] D00306 D00306, D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
424 |
Cannabidiol botanical drug substance (cbd bds) |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
425 |
Cannabidiol capsule 5 mg |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
426 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 [8] 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
427 |
Cannabis based medicine extract (sativex) |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
428 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 [5] 2 , 6 , 13, 96, 97 💬 |
429 |
Cannador |
- |
- |
- |
- |
013 [1] 13 💬 |
430 |
Caprylic triglyceride |
Tricaprylin |
- |
- |
- |
013 [1] 13 💬 |
431 |
Capsules with 160 mg teavigo (at least 94% egcg) |
Epigallocatechin gallate |
- |
- |
- |
013 [1] 13 💬 |
432 |
Carbamazepine |
Carbamazepine |
[1] D00252 D00252 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [2] 13, 231 💬 |
433 |
Carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [9] 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
434 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 [12] 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
435 |
Carmustine |
Carmustine |
[1] D00254 D00254 💬 |
- |
- |
011 [5] 11, 13, 14, 28, 60 💬 |
436 |
Carmustine, etoposide, cytarabine, and melphalan (beam) |
Carmustine |
[7] D00125 D00125, D00168 D00168, D00254 D00254, D00369 D00369, D03046 D03046, D03637 D03637, D04107 D04107 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
437 |
Carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 [8] 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
438 |
Carnosine |
Carnosine |
- |
- |
- |
006 [2] 6 , 13 💬 |
439 |
Carnosine, capsulle, 2 g/day, 8 weeks |
Carnosine |
- |
- |
- |
013 [1] 13 💬 |
440 |
Cbd |
- |
- |
- |
- |
002 [11] 2 , 6 , 8 , 13, 46, 140, 144, 145, 156, 158, 206 💬 |
441 |
Cc |
- |
- |
- |
- |
013 [13] 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
442 |
Cci-779 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
443 |
Cdp323 |
CDP323 |
- |
- |
- |
013 [1] 13 💬 |
444 |
Cellcept |
- |
- |
- |
- |
011 [5] 11, 13, 42, 43, 49 💬 |
445 |
Cellular therapy with ebv specific autologous ctl infusion |
- |
- |
- |
- |
013 [1] 13 💬 |
446 |
Ceralifimod |
Ceralifimod |
- |
- |
- |
013 [1] 13 💬 |
447 |
Ceralifmod |
- |
- |
- |
- |
013 [1] 13 💬 |
448 |
Cesamet™ (nabilone) |
Nabilone |
[1] D05099 D05099 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
449 |
Ceterizine |
- |
- |
- |
- |
013 [1] 13 💬 |
450 |
Cetirizina |
Cetirizine |
[2] D00664 D00664, D07662 D07662 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
451 |
Cetirizina mylan generics |
Cetirizine |
[2] D00664 D00664, D07662 D07662 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
452 |
Cetirizine |
Cetirizine |
[2] D00664 D00664, D07662 D07662 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [2] 13, 35 💬 |
453 |
Cetirizine hydrochloride |
Cetirizine |
[2] D00664 D00664, D07662 D07662 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
454 |
Cgp 77116 |
- |
- |
- |
- |
013 [1] 13 💬 |
455 |
Charcoal |
- |
- |
- |
- |
013 [1] 13 💬 |
456 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
457 |
Cholecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [9] 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
458 |
Cholecalciferol (vitamin d3) |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [2] 13, 299 💬 |
459 |
Cholecalciferol, vitamin d3 |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [1] 13 💬 |
460 |
Cholestyramine |
Cholestyramine |
- |
- |
- |
013 [2] 13, 79 💬 |
461 |
Chr-1103 / gbr500 |
- |
- |
- |
- |
013 [1] 13 💬 |
462 |
Cianocobalamina |
Cyanocobalamin |
[4] D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
013 [1] 13 💬 |
463 |
Cianocobalamina fu dc.it |
Cyanocobalamin |
[4] D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
013 [1] 13 💬 |
464 |
Ciclofosfamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
013 [1] 13 💬 |
465 |
Cinryze |
- |
- |
- |
- |
013 [2] 13, 61 💬 |
466 |
Circadin |
- |
- |
- |
- |
006 [3] 6 , 13, 90 💬 |
467 |
Circadin ( inn= melatonin) |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
468 |
Cisapride |
Cisapride |
[2] D00274 D00274, D02092 D02092 💬 |
HTR2A [3] HTR2A, HTR3A, HTR4 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
469 |
Citalopram |
Citalopram |
[2] D00822 D00822, D07704 D07704 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [6] 6 , 8 , 13, 18, 46, 127 💬 |
470 |
Citochine ed immunomodulatori |
- |
- |
- |
- |
013 [1] 13 💬 |
471 |
Cladribina |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
472 |
Cladribina oral |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
473 |
Cladribine |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [2] 13, 94 💬 |
474 |
Cladribine 3.5 mg/kg |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
475 |
Cladribine 5.25 mg/kg |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
476 |
Cladribine oral tablet |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
477 |
Cladribine tablet |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
478 |
Cladribine tablets |
Cladribine |
[1] D01370 D01370 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
479 |
Clemastine |
Clemastine |
[2] D00666 D00666, D03535 D03535 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
480 |
Clemastine fumarate |
Clemastine |
[2] D00666 D00666, D03535 D03535 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
481 |
Clostridium botulinum |
Clostridium botulinum |
- |
- |
- |
013 [1] 13 💬 |
482 |
Clostridium botulinum toxin type a |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
013 [1] 13 💬 |
483 |
Cnm-au8 |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
484 |
Cnp-ms-0601 |
- |
- |
- |
- |
013 [1] 13 💬 |
485 |
Cnto 1275 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
486 |
Co |
- |
- |
- |
- |
006 [5] 6 , 13, 53, 70, 85 💬 |
487 |
Co-14 |
- |
- |
- |
- |
013 [1] 13 💬 |
488 |
Coconut |
Coconut |
- |
- |
- |
013 [2] 13, 53 💬 |
489 |
Coconut oil |
Coconut |
[1] D05326 D05326 💬 |
- |
- |
013 [1] 13 💬 |
490 |
Coconut oil and epigallocatechin gallate |
Coconut |
[1] D05326 D05326 💬 |
- |
- |
013 [1] 13 💬 |
491 |
Coenzyme q |
- |
- |
- |
- |
013 [1] 13 💬 |
492 |
Colecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [4] 13, 46, 96, 228 💬 |
493 |
Colecalciferol concentrate (oily form) |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [1] 13 💬 |
494 |
Combination product: ofatumumab with ai |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
495 |
Combination product: ofatumumab with prf |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
496 |
Cop |
- |
- |
- |
- |
013 [1] 13 💬 |
497 |
Cop-1 |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
498 |
Cop-1/copolymer-1 |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
499 |
Copaxone |
- |
- |
- |
- |
013 [1] 13 💬 |
500 |
Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe |
- |
- |
- |
- |
013 [1] 13 💬 |
501 |
Copaxone - 40 mg/ml soluzione iniettabile in siringa preriempita 12 siringhe preriempite da 1 ml con ago |
- |
- |
- |
- |
013 [1] 13 💬 |
502 |
Copaxone 20 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
503 |
Copaxone 20 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
504 |
Copaxone 20 mg/ml solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
505 |
Copaxone 20 mg/ml solución para inyección en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
506 |
Copaxone 20 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
507 |
Copaxone 20 mg/ml, solution for injection, pre-filled syringes |
- |
- |
- |
- |
013 [1] 13 💬 |
508 |
Copaxone 20mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
509 |
Copaxone 40 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
510 |
Copaxone 40 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
511 |
Copaxone subcutaneous injection syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
512 |
Copaxone*sc 28sir 20mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
513 |
Copaxone-teva |
- |
- |
- |
- |
013 [1] 13 💬 |
514 |
Copaxone® |
- |
- |
- |
- |
013 [1] 13 💬 |
515 |
Copolymer 1 |
- |
- |
- |
- |
013 [1] 13 💬 |
516 |
Copolymer-1 |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
517 |
Corticosteroid |
- |
- |
- |
- |
013 [10] 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
518 |
Corticosteroids & tancart19/20 |
- |
- |
- |
- |
013 [1] 13 💬 |
519 |
Corticotropin |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [7] 2 , 13, 46, 75, 78, 84, 222 💬 |
520 |
Cranberry |
Cranberry |
- |
- |
- |
013 [1] 13 💬 |
521 |
Creatine |
Creatine |
- |
- |
- |
001 [12] 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
522 |
Cs-0777 tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
523 |
Ct103a cells |
- |
- |
- |
- |
013 [1] 13 💬 |
524 |
Curcumin |
Curcumin |
- |
- |
- |
002 [11] 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
525 |
Cyclophosfamide |
- |
- |
- |
- |
013 [1] 13 💬 |
526 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
527 |
Cyclophosphamide (drug) |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
013 [1] 13 💬 |
528 |
Cyclophosphamide and atg |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
013 [1] 13 💬 |
529 |
Cyclophosphamide and fludarabine |
Cyclophosphamide |
[4] D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [1] 13 💬 |
530 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
013 [4] 13, 60, 96, 256 💬 |
531 |
Cyclophosphamide/glatiramer acetate |
Acetate |
[3] D00287 D00287, D04318 D04318, D07760 D07760 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
532 |
Cymbalta |
- |
- |
- |
- |
006 [3] 6 , 13, 49 💬 |
533 |
Cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
006 [11] 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
534 |
Cytarabine |
Cytarabine |
[3] D00168 D00168, D03046 D03046, D03637 D03637 💬 |
- |
- |
011 [6] 11, 13, 14, 25, 49, 60 💬 |
535 |
Cytolytic cd4+ t cells |
- |
- |
- |
- |
013 [1] 13 💬 |
536 |
Cápsulas de laquinimod 0.6 mg |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
537 |
Células madre mesenquimales |
- |
- |
- |
- |
013 [1] 13 💬 |
538 |
D mannose |
Mannose |
- |
- |
- |
013 [1] 13 💬 |
539 |
D-aspartate |
- |
- |
- |
- |
013 [1] 13 💬 |
540 |
D-biotin |
Biotin |
[1] D00029 D00029 💬 |
- |
- |
010 [3] 10, 13, 20 💬 |
541 |
D-biotina |
Biotin |
[1] D00029 D00029 💬 |
- |
- |
013 [1] 13 💬 |
542 |
Dac |
- |
- |
- |
- |
013 [3] 13, 90, 301 💬 |
543 |
Dac hyp |
- |
- |
- |
- |
013 [1] 13 💬 |
544 |
Dac-hyp |
- |
- |
- |
- |
013 [1] 13 💬 |
545 |
Daclizumab |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [7] 13, 56, 60, 65, 97, 283, 284 💬 |
546 |
Daclizumab (anti-cd25 humanized monoclonal antibody) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
547 |
Daclizumab high yield process |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
548 |
Daclizumab hyp |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
549 |
Daclizumab hyp (dac hyp |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
550 |
Daclizumab hyp (dac hyp) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
551 |
Daclizumab wih greek suffix |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
552 |
Daclizumab with greek suufix |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
553 |
Dalfampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
004 [2] 4 , 13 💬 |
554 |
Dalfampridine er |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
555 |
Dalfampridine-er 10mg |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
556 |
Dalfampridine-er 5mg |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
557 |
Dantrolene |
Dantrolene |
[2] D02274 D02274, D02347 D02347 💬 |
- |
- |
013 [2] 13, 233 💬 |
558 |
Dapirolizumab pegol |
Dapirolizumab pegol |
- |
- |
- |
013 [2] 13, 49 💬 |
559 |
Darifenacin |
Darifenacin |
[2] D01699 D01699, D03654 D03654 💬 |
CHRM3 [1] CHRM3 💬 |
Alzheimer disease [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 [2] 6 , 13 💬 |
560 |
Darifenacin (bay79-4998) |
Darifenacin |
[2] D01699 D01699, D03654 D03654 💬 |
CHRM3 [1] CHRM3 💬 |
Alzheimer disease [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
013 [1] 13 💬 |
561 |
Dc-tab |
- |
- |
- |
- |
013 [1] 13 💬 |
562 |
Dekristol |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
563 |
Dekristol 20000 ie |
- |
- |
- |
- |
013 [1] 13 💬 |
564 |
Dekristol® 400-tabletten |
- |
- |
- |
- |
013 [1] 13 💬 |
565 |
Dekristol®-tablette 1 (400 ie) |
- |
- |
- |
- |
013 [1] 13 💬 |
566 |
Delta-9-tetrahydrocannabinol |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 [2] 8 , 13 💬 |
567 |
Demestril septem |
- |
- |
- |
- |
013 [1] 13 💬 |
568 |
Device: 2 ma transcranial direct current stimulation |
- |
- |
- |
- |
013 [1] 13 💬 |
569 |
Device: 4 ma transcranial direct current stimulation |
- |
- |
- |
- |
013 [1] 13 💬 |
570 |
Device: avonex prefilled syringe via manual im injection |
- |
- |
- |
- |
013 [1] 13 💬 |
571 |
Device: balance platform therapy |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
572 |
Device: betaconnect |
- |
- |
- |
- |
013 [1] 13 💬 |
573 |
Device: betaconnect auto-injector |
- |
- |
- |
- |
013 [1] 13 💬 |
574 |
Device: betaconnect auto-injector. |
- |
- |
- |
- |
013 [1] 13 💬 |
575 |
Device: betaconnect autoinjector |
- |
- |
- |
- |
013 [1] 13 💬 |
576 |
Device: betaconnect device |
- |
- |
- |
- |
013 [1] 13 💬 |
577 |
Device: biib017 (peginterferon beta-1a) autoinjector |
Peginterferon beta-1a |
[1] D10483 D10483 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
578 |
Device: biib017 (peginterferon beta-1a) pre-filled syringe (pfs) |
Peginterferon beta-1a |
[1] D10483 D10483 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
579 |
Device: capacity of muscular oxygen extraction |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
013 [1] 13 💬 |
580 |
Device: cic using lofric primo |
- |
- |
- |
- |
013 [1] 13 💬 |
581 |
Device: dynamic vessel analyzer (dva) |
- |
- |
- |
- |
013 [1] 13 💬 |
582 |
Device: extracorporeal photopheresis |
- |
- |
- |
- |
013 [1] 13 💬 |
583 |
Device: four-point cane (fpc) |
- |
- |
- |
- |
013 [1] 13 💬 |
584 |
Device: fourier domain doppler optical coherence tomography (fdoct) |
- |
- |
- |
- |
013 [1] 13 💬 |
585 |
Device: interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
586 |
Device: lokomat training |
- |
- |
- |
- |
013 [1] 13 💬 |
587 |
Device: magnetic resonance imaging |
- |
- |
- |
- |
006 [5] 6 , 13, 22, 34, 299 💬 |
588 |
Device: medication event monitoring system (mems) |
- |
- |
- |
- |
013 [1] 13 💬 |
589 |
Device: metabolic fatigue |
- |
- |
- |
- |
013 [1] 13 💬 |
590 |
Device: mybetaapp |
- |
- |
- |
- |
013 [1] 13 💬 |
591 |
Device: neuromuscular electrical stimulation delivered using the electrical therapy device empi 300 pv |
- |
- |
- |
- |
013 [1] 13 💬 |
592 |
Device: nintendo wii fit balance board |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
593 |
Device: nirs after bosentan administration |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
594 |
Device: nirs baseline |
- |
- |
- |
- |
013 [1] 13 💬 |
595 |
Device: optical coherence tomography (oct) |
- |
- |
- |
- |
013 [1] 13 💬 |
596 |
Device: optical coherence tomography angiography (octa) |
- |
- |
- |
- |
013 [1] 13 💬 |
597 |
Device: paired associative stimulation (pas) |
- |
- |
- |
- |
013 [1] 13 💬 |
598 |
Device: repetitive transcranial magnetic stimulation (rtms) |
- |
- |
- |
- |
013 [1] 13 💬 |
599 |
Device: sham transcranial direct current stimulation (tdcs) |
- |
- |
- |
- |
013 [1] 13 💬 |
600 |
Device: single-point cane (spc) |
- |
- |
- |
- |
013 [1] 13 💬 |
601 |
Device: single-pulse transcranial magnetic stimulation (sptms) |
- |
- |
- |
- |
013 [1] 13 💬 |
602 |
Device: single-use autoinjector |
- |
- |
- |
- |
013 [1] 13 💬 |
603 |
Device: single-use autoinjector with a prefilled liquid avonex syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
604 |
Device: sleep assessment |
- |
- |
- |
- |
013 [1] 13 💬 |
605 |
Device: tcd after bosentan administration |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
606 |
Device: tcd baseline |
- |
- |
- |
- |
013 [1] 13 💬 |
607 |
Device: transcranial magnetic stimulation (tms) |
- |
- |
- |
- |
013 [1] 13 💬 |
608 |
Device: trekking pole (tp). |
- |
- |
- |
- |
013 [1] 13 💬 |
609 |
Device: video game therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
610 |
Device: wristband physical activity monitor |
Methamidophos |
- |
- |
- |
013 [1] 13 💬 |
611 |
Dexamethason |
- |
- |
- |
- |
013 [4] 13, 28, 46, 331 💬 |
612 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
613 |
Dexamethasone soduim phosphate |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
614 |
Dexchlorpheniramine |
Dexchlorpheniramine |
[1] D07803 D07803 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
615 |
Dexrazoxane |
Dexrazoxane |
[1] D03730 D03730 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
616 |
Dexrazoxane (drz) plus mitoxantrone (mx) |
Dexrazoxane |
[3] D02166 D02166, D03730 D03730, D08224 D08224 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
617 |
Dextromethorphan |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
618 |
Dextromethorphan hydrobromide |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 [2] 13, 46 💬 |
619 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [2] 2 , 13 💬 |
620 |
Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [2] 2 , 13 💬 |
621 |
Dextromethorphan/quinidine |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
622 |
Dextrometorfano |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 [1] 13 💬 |
623 |
Dextrometorfano hidrobromuro |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 [1] 13 💬 |
624 |
Dextrometorfano/quinidina |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
625 |
Diagnostic test: entire-body pet-ct scans |
- |
- |
- |
- |
013 [1] 13 💬 |
626 |
Diagnostic test: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
013 [3] 13, 65, 299 💬 |
627 |
Diagnostic test: pet with [11c]flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 [1] 13 💬 |
628 |
Diagnostic test: stroop test |
- |
- |
- |
- |
013 [1] 13 💬 |
629 |
Diagnostic test: testing of autonomous nervous system function |
- |
- |
- |
- |
013 [1] 13 💬 |
630 |
Diazoxide |
Diazoxide |
[1] D00294 D00294 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
013 [2] 13, 193 💬 |
631 |
Dibase |
- |
- |
- |
- |
013 [1] 13 💬 |
632 |
Diclofenac |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [4] 13, 34, 46, 271 💬 |
633 |
Diclofenac sodium topical gel |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
634 |
Dietary supplement: vitamin a |
Vitamin A |
[2] D00069 D00069, D06543 D06543 💬 |
RARA [2] RARA, RARB 💬 |
Acute myeloid leukemia [8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
013 [1] 13 💬 |
635 |
Dimethyl fumarate |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [4] 13, 51, 86, 296 💬 |
636 |
Dimethyl fumarate (dmf) |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [3] 13, 51, 86 💬 |
637 |
Dimethyl fumarate 240 mg |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [1] 13 💬 |
638 |
Dimethyl fumarate [dmf] |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [1] 13 💬 |
639 |
Dimetilfumarato |
- |
- |
- |
- |
013 [1] 13 💬 |
640 |
Diphenydramine |
- |
- |
- |
- |
013 [1] 13 💬 |
641 |
Diphtheria toxoid |
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [2] 13, 46 💬 |
642 |
Diroximel fumarate |
Diroximel fumarate |
[1] D11154 D11154 💬 |
- |
- |
013 [1] 13 💬 |
643 |
Diroximel fumarate (drf) |
Diroximel fumarate |
[1] D11154 D11154 💬 |
- |
- |
013 [1] 13 💬 |
644 |
Dirucotide |
Dirucotide |
[1] D09396 D09396 💬 |
- |
- |
013 [1] 13 💬 |
645 |
Dirucotide acetate |
Acetate |
[1] D09396 D09396 💬 |
- |
- |
013 [1] 13 💬 |
646 |
Discontinuation of disease modifying therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
647 |
Disease modifying therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
648 |
Dmt |
- |
- |
- |
- |
013 [1] 13 💬 |
649 |
Dmt continuation |
- |
- |
- |
- |
013 [1] 13 💬 |
650 |
Domperidone |
Domperidone |
[2] D01745 D01745, D07868 D07868 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [5] 6 , 13, 17, 51, 230 💬 |
651 |
Donepezil |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
005 [9] 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
652 |
Donepezil hci (drug) |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
013 [1] 13 💬 |
653 |
Dosing interruption of natalizumab |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
654 |
Dotarem |
- |
- |
- |
- |
013 [1] 13 💬 |
655 |
Dotarem 0,5mmol/ml, |
- |
- |
- |
- |
013 [1] 13 💬 |
656 |
Doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 [15] 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
657 |
Dpa |
- |
- |
- |
- |
002 [4] 2 , 6 , 13, 85 💬 |
658 |
Dpa-714 pet/mri |
- |
- |
- |
- |
013 [1] 13 💬 |
659 |
Dronabinol |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
002 [5] 2 , 13, 46, 271, 298 💬 |
660 |
Dronabinol 25 mg/ml, oral drops |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
661 |
Dronabinol capsule 2,5 mg |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
662 |
Duloxetine |
Duloxetine |
[2] D01179 D01179, D07880 D07880 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 13 💬 |
663 |
Duloxetine hydrochloride (hci) |
Duloxetine |
[2] D01179 D01179, D07880 D07880 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [1] 13 💬 |
664 |
Dydrogesterone |
Dydrogesterone |
[1] D01217 D01217 💬 |
PGR [1] PGR 💬 |
Breast cancer [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 [1] 13 💬 |
665 |
Dysport |
- |
- |
- |
- |
013 [2] 13, 36 💬 |
666 |
Dysport*sc im 2fl 500u |
- |
- |
- |
- |
013 [1] 13 💬 |
667 |
Dysport® |
- |
- |
- |
- |
013 [1] 13 💬 |
668 |
Early highly effective therapies group |
- |
- |
- |
- |
013 [1] 13 💬 |
669 |
Ebixa |
- |
- |
- |
- |
002 [3] 2 , 6 , 13 💬 |
670 |
Ecp002a |
- |
- |
- |
- |
013 [1] 13 💬 |
671 |
Eculizumab |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
011 [8] 11, 13, 14, 61, 62, 109, 222, 223 💬 |
672 |
Efalizumab |
Efalizumab |
[1] D03959 D03959 💬 |
ITGAL [1] ITGAL 💬 |
Cell adhesion molecules [12] Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 [8] 11, 13, 37, 46, 53, 61, 95, 96 💬 |
673 |
Egb 761® (tanakan®) |
Ginkgo biloba |
- |
- |
- |
013 [1] 13 💬 |
674 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 [9] 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
675 |
Ek-12 |
- |
- |
- |
- |
013 [1] 13 💬 |
676 |
Elezanumab |
Elezanumab |
[1] D11355 D11355 💬 |
RGMA [1] RGMA 💬 |
Axon guidance [2] Axon guidance, TGF-beta signaling pathway |
013 [1] 13 💬 |
677 |
Elnd002 |
- |
- |
- |
- |
013 [1] 13 💬 |
678 |
Emd 28162 |
- |
- |
- |
- |
013 [1] 13 💬 |
679 |
Emselex |
- |
- |
- |
- |
013 [1] 13 💬 |
680 |
Emselex 15 mg retardtabletten |
- |
- |
- |
- |
013 [1] 13 💬 |
681 |
Emselex 7,5 mg retardtabletten |
- |
- |
- |
- |
013 [1] 13 💬 |
682 |
Ena713 |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
683 |
Encapsulated baclofen 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
684 |
Encapsulated simvastatin tablets |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
685 |
Endoxan |
- |
- |
- |
- |
013 [7] 13, 28, 43, 44, 85, 96, 222 💬 |
686 |
Endoxan - ciclofosfamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
013 [1] 13 💬 |
687 |
Endoxan baxter |
- |
- |
- |
- |
013 [3] 13, 43, 96 💬 |
688 |
Enriched hematopoetic stem cell infusion |
- |
- |
- |
- |
013 [3] 13, 19, 284 💬 |
689 |
Enspryng |
- |
- |
- |
- |
013 [1] 13 💬 |
690 |
Eparmefolin 30 cpr 0,1/0,5mg |
- |
- |
- |
- |
013 [1] 13 💬 |
691 |
Epigallocatechin |
Epigallocatechin |
- |
- |
- |
008 [5] 8 , 13, 28, 85, 113 💬 |
692 |
Epigallocatechin gallate |
Epigallocatechin |
- |
- |
- |
013 [1] 13 💬 |
693 |
Epigallocatechin-gallate (sunphenon) |
Epigallocatechin |
- |
- |
- |
013 [1] 13 💬 |
694 |
Epo |
- |
- |
- |
- |
013 [1] 13 💬 |
695 |
Epoetin alfa |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 [3] 13, 18, 46 💬 |
696 |
Epoetin beta |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 [1] 13 💬 |
697 |
Equal |
- |
- |
- |
- |
006 [5] 6 , 13, 67, 86, 230 💬 |
698 |
Erypo/erypo fs |
- |
- |
- |
- |
013 [1] 13 💬 |
699 |
Erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [9] 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
700 |
Escalation therapies group |
- |
- |
- |
- |
013 [1] 13 💬 |
701 |
Escitalopram |
Escitalopram |
[3] D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
002 [3] 2 , 6 , 13 💬 |
702 |
Escitalopram oxalate antidepressant |
Escitalopram |
[3] D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [1] 13 💬 |
703 |
Esomeprazole |
Esomeprazole |
[4] D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 [6] 13, 46, 86, 98, 298, 299 💬 |
704 |
Essential - hydroxytyrosol |
Hydroxytyrosol |
- |
- |
- |
013 [1] 13 💬 |
705 |
Essential fatty acids |
- |
- |
- |
- |
013 [1] 13 💬 |
706 |
Estradiol |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [5] 13, 46, 49, 226, 299 💬 |
707 |
Estradiol hemihydrate |
Estradiol |
[8] D00105 D00105, D01413 D01413, D01617 D01617, D01953 D01953, D04061 D04061, D04063 D04063, D04064 D04064, D04065 D04065 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [1] 13 💬 |
708 |
Estriol |
Estriol |
[2] D00185 D00185, D01986 D01986 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [2] 13, 227 💬 |
709 |
Estroprogestins |
- |
- |
- |
- |
013 [1] 13 💬 |
710 |
Eszopiclone |
Eszopiclone |
[1] D02624 D02624 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [3] 6 , 13, 46 💬 |
711 |
Ethinylestradiol |
Ethinylestradiol |
[1] D00554 D00554 💬 |
ESR1 [1] ESR1 💬 |
Breast cancer [8] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [1] 13 💬 |
712 |
Etifoxine |
Etifoxine |
[1] D07320 D07320 💬 |
- |
- |
013 [1] 13 💬 |
713 |
Etims |
- |
- |
- |
- |
013 [1] 13 💬 |
714 |
Etims (edc-fixed autologous pbmcs coupled with 7 immunodominant myelin peptides in ms patients) |
- |
- |
- |
- |
013 [1] 13 💬 |
715 |
Etoposide |
Etoposide |
[2] D00125 D00125, D04107 D04107 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
011 [11] 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
716 |
Eu/1/08/454/001-002, eu/1/08/454/005-007 |
- |
- |
- |
- |
013 [1] 13 💬 |
717 |
Eu/1/95/003/005-010 |
- |
- |
- |
- |
013 [1] 13 💬 |
718 |
Eu/1/97/033/002 |
- |
- |
- |
- |
013 [1] 13 💬 |
719 |
Eu/1/98/063/001-003 |
- |
- |
- |
- |
013 [1] 13 💬 |
720 |
Eu/1/98/063/004-006 |
- |
- |
- |
- |
013 [1] 13 💬 |
721 |
Evobrutinib |
Evobrutinib |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
722 |
Evobrutinib 10mg |
Evobrutinib |
- |
- |
- |
013 [1] 13 💬 |
723 |
Evobrutinib 25mg |
Evobrutinib |
- |
- |
- |
013 [1] 13 💬 |
724 |
Exelon |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
725 |
Exelon transdermales pflaster |
- |
- |
- |
- |
013 [1] 13 💬 |
726 |
Experimental glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
727 |
Exposure to one or more disease-modifying drug(s)(dmds) used to treat ms |
- |
- |
- |
- |
013 [1] 13 💬 |
728 |
Extavia |
- |
- |
- |
- |
013 [1] 13 💬 |
729 |
Extavia (interferon beta-1b), novartis pharma ag |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
730 |
Extavia 250 microgram/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
731 |
Extavia 250 micrograms/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
732 |
Extavia*sc 15fl 250mcg/ml+15si |
- |
- |
- |
- |
013 [1] 13 💬 |
733 |
Extavia® |
- |
- |
- |
- |
013 [1] 13 💬 |
734 |
Extended release fampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
735 |
Extended-release oxycodone |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
736 |
Extended-release quetiapine fumarate |
Quetiapine |
[2] D00458 D00458, D08456 D08456 💬 |
DRD2 [2] DRD2, HTR2A 💬 |
Alcoholism [11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
013 [1] 13 💬 |
737 |
F-18 fedaa1106 (bay85-8101) |
- |
- |
- |
- |
013 [1] 13 💬 |
738 |
Famciclovir |
Famciclovir |
[1] D00317 D00317 💬 |
- |
- |
013 [1] 13 💬 |
739 |
Fampridina |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
740 |
Fampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [2] 13, 14 💬 |
741 |
Fampridine sr |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
742 |
Fampridine-sr |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
743 |
Fampridine-sr b.i.d. (twice daily) |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
744 |
Fampyra |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
745 |
Fampyra - 10 mg - compressa a rilascio prolungato - uso orale - flacone (hdpe) 56 compresse (4 flaconi da 14) |
- |
- |
- |
- |
013 [1] 13 💬 |
746 |
Fampyra 10 mg prolonged-release tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
747 |
Fampyra 10mg prolonged release tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
748 |
Fatigue |
- |
- |
- |
- |
013 [1] 13 💬 |
749 |
Febuxostat |
Febuxostat |
[1] D01206 D01206 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
002 [3] 2 , 6 , 13 💬 |
750 |
Fecal microbial transplant (fmt) |
- |
- |
- |
- |
013 [1] 13 💬 |
751 |
Fecal microbial transplants |
- |
- |
- |
- |
013 [1] 13 💬 |
752 |
Fecal microbiota |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
753 |
Femoston 1/10 |
- |
- |
- |
- |
013 [1] 13 💬 |
754 |
Femoston 2/10 |
- |
- |
- |
- |
013 [1] 13 💬 |
755 |
Fenebrutinib |
Fenebrutinib |
[1] D11457 D11457 💬 |
BTK [1] BTK 💬 |
B cell receptor signaling pathway [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
013 [1] 13 💬 |
756 |
Feraheme |
- |
- |
- |
- |
013 [1] 13 💬 |
757 |
Ferumoxytol |
Ferumoxytol |
[1] D04177 D04177 💬 |
- |
- |
013 [1] 13 💬 |
758 |
Filgrastim |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [27] 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
759 |
Fingolimob (fty) |
- |
- |
- |
- |
013 [1] 13 💬 |
760 |
Fingolimod |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [3] 13, 14, 156 💬 |
761 |
Fingolimod (fty720) |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 156 💬 |
762 |
Fingolimod 0.5 mg |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
763 |
Fingolimod 1.25 mg |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
764 |
Fingolimod hydrochloride |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 14 💬 |
765 |
Fingolimodi |
- |
- |
- |
- |
013 [1] 13 💬 |
766 |
Fingolmod |
- |
- |
- |
- |
013 [1] 13 💬 |
767 |
Firategrast |
Firategrast |
[1] D06590 D06590 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
768 |
Firategrast (usan approved name) |
Firategrast |
[1] D06590 D06590 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
769 |
Firategrast 150 mg |
Firategrast |
[1] D06590 D06590 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
770 |
Firategrast 300 mg |
Firategrast |
[1] D06590 D06590 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
771 |
Firategrast gastro-retentive solution |
Firategrast |
[1] D06590 D06590 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
772 |
Firategrast immediate release tablet |
Firategrast |
[1] D06590 D06590 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
773 |
Firategrast modified release tablet |
Firategrast |
[1] D06590 D06590 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
774 |
Fish oil |
Fish oil |
- |
- |
- |
013 [7] 13, 46, 49, 66, 96, 260, 299 💬 |
775 |
Fish oil concentrate |
Fish oil |
- |
- |
- |
013 [1] 13 💬 |
776 |
Fish oil, rich in omega-3-acids |
Fish oil |
- |
- |
- |
013 [1] 13 💬 |
777 |
Fish oil,rich in omega 3 acids |
Fish oil |
- |
- |
- |
013 [1] 13 💬 |
778 |
Fludara |
- |
- |
- |
- |
013 [1] 13 💬 |
779 |
Fludarabine |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
780 |
Flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [5] 6 , 13, 17, 18, 206 💬 |
781 |
Fluoxetin |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [3] 13, 179, 206 💬 |
782 |
Fluoxetin hexal |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [1] 13 💬 |
783 |
Fluoxetine |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [4] 13, 17, 78, 86 💬 |
784 |
Fluoxetine hydrochloride |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [1] 13 💬 |
785 |
Flupirtin |
- |
- |
- |
- |
013 [1] 13 💬 |
786 |
Flupirtine |
Flupirtine |
[1] D07978 D07978 💬 |
- |
- |
013 [1] 13 💬 |
787 |
Flupirtinmaleat |
- |
- |
- |
- |
013 [1] 13 💬 |
788 |
Flurbiprofen |
Flurbiprofen |
[3] D00330 D00330, D01475 D01475, D02290 D02290 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [3] 13, 21, 46 💬 |
789 |
Fmp30 donor stool |
- |
- |
- |
- |
013 [1] 13 💬 |
790 |
Folate |
Folic acid |
[1] D00070 D00070 💬 |
- |
- |
013 [3] 13, 46, 49 💬 |
791 |
Folatescan (technetium tc 99mec20) |
- |
- |
- |
- |
013 [4] 13, 46, 49, 96 💬 |
792 |
Formistin |
- |
- |
- |
- |
013 [1] 13 💬 |
793 |
Formistin - 10 mg compresse rivestite con film 20 compresse |
- |
- |
- |
- |
013 [1] 13 💬 |
794 |
Formistin 10 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
795 |
Formulation a |
- |
- |
- |
- |
013 [1] 13 💬 |
796 |
Formulation b |
- |
- |
- |
- |
013 [1] 13 💬 |
797 |
Formulation c |
- |
- |
- |
- |
013 [1] 13 💬 |
798 |
Formulation d |
- |
- |
- |
- |
013 [1] 13 💬 |
799 |
Fpc |
- |
- |
- |
- |
013 [1] 13 💬 |
800 |
Freshly-pressed extra virgin olive oil |
Olea europaea leaf |
[1] D03311 D03311 💬 |
- |
- |
013 [1] 13 💬 |
801 |
Fty720 |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
802 |
Fty720d |
- |
- |
- |
- |
013 [1] 13 💬 |
803 |
Full spectrum vitamin |
- |
- |
- |
- |
013 [1] 13 💬 |
804 |
Fully humanized anti-human il-6 receptor (il-6r) neutralizing monoclonal antibody |
- |
- |
- |
- |
013 [1] 13 💬 |
805 |
Fumaric acid |
Fumaric Acid |
[1] D02308 D02308 💬 |
- |
- |
013 [1] 13 💬 |
806 |
G-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [16] 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
807 |
G2-sfm (ifn-beta-1a from clone 484-39,fbs-free process) |
- |
- |
- |
- |
013 [1] 13 💬 |
808 |
Ga |
- |
- |
- |
- |
013 [1] 13 💬 |
809 |
Ga 20 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
810 |
Ga 40 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
811 |
Ga depot |
- |
- |
- |
- |
013 [1] 13 💬 |
812 |
Ga depot 40 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
813 |
Ga depot 40mg once monthly |
- |
- |
- |
- |
013 [1] 13 💬 |
814 |
Ga depot 80 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
815 |
Gabapentin |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [5] 6 , 13, 19, 70, 298 💬 |
816 |
Gabapentine |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
013 [1] 13 💬 |
817 |
Gabapentine 300mg |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
013 [1] 13 💬 |
818 |
Gadobenate |
Gadobenic acid |
[2] D04283 D04283, D08018 D08018 💬 |
- |
- |
013 [1] 13 💬 |
819 |
Gadobenate dimeglumine |
Gadobenic acid |
[2] D04283 D04283, D08018 D08018 💬 |
- |
- |
013 [1] 13 💬 |
820 |
Gadobutrol |
Gadobutrol |
[1] D07420 D07420 💬 |
- |
- |
013 [3] 13, 22, 46 💬 |
821 |
Gadolinium |
Gadolinium |
- |
- |
- |
013 [6] 13, 34, 46, 58, 65, 86 💬 |
822 |
Gadolinium-based contrast |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
823 |
Gadopentetate |
Gadopentetic acid |
[2] D01707 D01707, D08006 D08006 💬 |
- |
- |
013 [2] 13, 34 💬 |
824 |
Gadoteric acid |
Gadoteric acid |
[1] D08007 D08007 💬 |
- |
- |
013 [1] 13 💬 |
825 |
Gadoteridol |
Gadoteridol |
[1] D01137 D01137 💬 |
- |
- |
013 [1] 13 💬 |
826 |
Gadovist |
- |
- |
- |
- |
013 [2] 13, 22 💬 |
827 |
Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado |
- |
- |
- |
- |
013 [1] 13 💬 |
828 |
Gadovist 1.0 mmol/ml injektionslösung |
- |
- |
- |
- |
013 [1] 13 💬 |
829 |
Gamma-tocopherol |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
013 [1] 13 💬 |
830 |
Gbp |
- |
- |
- |
- |
013 [1] 13 💬 |
831 |
Gdc-0853 ro7010939 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
832 |
Genotropin |
- |
- |
- |
- |
013 [4] 13, 78, 187, 193 💬 |
833 |
Gilenya |
- |
- |
- |
- |
002 [3] 2 , 13, 14 💬 |
834 |
Gilenya / imusera |
- |
- |
- |
- |
013 [1] 13 💬 |
835 |
Gilenya 0,5 mg hartkapseln |
- |
- |
- |
- |
013 [1] 13 💬 |
836 |
Gilenya® |
- |
- |
- |
- |
013 [1] 13 💬 |
837 |
Gileyna |
- |
- |
- |
- |
013 [1] 13 💬 |
838 |
Ginkgo |
Ginkgo biloba |
- |
- |
- |
006 [4] 6 , 13, 18, 90 💬 |
839 |
Ginkgo biloba |
Ginkgo biloba |
- |
- |
- |
013 [3] 13, 18, 90 💬 |
840 |
Ginseng |
Ginseng |
[1] D06772 D06772 💬 |
- |
- |
013 [3] 13, 46, 53 💬 |
841 |
Gla |
- |
- |
- |
- |
013 [2] 13, 19 💬 |
842 |
Glatiramer |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 [4] 2 , 13, 96, 156 💬 |
843 |
Glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [3] 13, 96, 156 💬 |
844 |
Glatiramer acetate (copaxone®) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [2] 13, 156 💬 |
845 |
Glatiramer acetate (db) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
846 |
Glatiramer acetate (ga) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
847 |
Glatiramer acetate (ga) 40 mg |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
848 |
Glatiramer acetate (gtr) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
849 |
Glatiramer acetate (ol) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
850 |
Glatiramer acetate 150mg enteric coated tablets |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
851 |
Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
852 |
Glatiramer acetate 20 mg |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
853 |
Glatiramer acetate 20 mg, with mitoxantrone |
Acetate |
[3] D02166 D02166, D04318 D04318, D08224 D08224 💬 |
HLA-A [22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬 |
Allograft rejection [33] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
854 |
Glatiramer acetate 20 mg/0.5 ml |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
855 |
Glatiramer acetate 40 mg |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
856 |
Glatiramer acetate [ga] |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
857 |
Glatiramer acetate injection with oral cetirizine hydrochloride |
Acetate |
[3] D00664 D00664, D04318 D04318, D07662 D07662 💬 |
HLA-A [21] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬 |
Allograft rejection [35] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
858 |
Glatiramer acetate with minocycline |
Acetate |
[3] D00850 D00850, D04318 D04318, D05045 D05045 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
859 |
Glatiramer acetate, (copaxone®) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
860 |
Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
861 |
Glatiramer acetate, n-acetylcysteine |
Acetate |
[2] D00221 D00221, D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
862 |
Glatiramer acetato |
Glatiramer |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
863 |
Glatiramero acetato |
- |
- |
- |
- |
013 [1] 13 💬 |
864 |
Glicerol-1,3-didecanoato-2-octadeca-(6z,9z,12z)-trienoato |
- |
- |
- |
- |
013 [1] 13 💬 |
865 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 [15] 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
866 |
Glutamate and aspartate |
- |
- |
- |
- |
013 [1] 13 💬 |
867 |
Glycerol |
Glycerin |
[1] D00028 D00028 💬 |
- |
- |
006 [5] 6 , 13, 79, 316, 317 💬 |
868 |
Glycerol-1,3-didecanoate-2-octadeca-(6z,9z,12z)-trienoate |
Glycerin |
[1] D00028 D00028 💬 |
- |
- |
013 [1] 13 💬 |
869 |
Gnbac1 |
- |
- |
- |
- |
013 [1] 13 💬 |
870 |
Gnbac1 monoclonal antibody |
- |
- |
- |
- |
013 [1] 13 💬 |
871 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
872 |
Gold nanocrystals |
- |
- |
- |
- |
002 [3] 2 , 6 , 13 💬 |
873 |
Granulocyte-colony stimulating factor (g-csf) and prednisone |
Filgrastim |
[2] D00473 D00473, D03235 D03235 💬 |
CSF3R [2] CSF3R, NR3C1 💬 |
Cytokine-cytokine receptor interaction [6] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer |
013 [1] 13 💬 |
874 |
Growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 [12] 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
875 |
Gsk1223249 |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
876 |
Gsk1841157 |
- |
- |
- |
- |
013 [3] 13, 35, 46 💬 |
877 |
Gsk2018682 |
- |
- |
- |
- |
013 [1] 13 💬 |
878 |
Gsk2018682 cd2 capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
879 |
Gsk2018682 cd3 micronised tablet |
- |
- |
- |
- |
013 [1] 13 💬 |
880 |
Gsk2018682 cd3 non-micronised tablet |
- |
- |
- |
- |
013 [1] 13 💬 |
881 |
Gsk2018682 cd3 non-micronised tablet in fed state |
- |
- |
- |
- |
013 [1] 13 💬 |
882 |
Gsk239512 |
- |
- |
- |
- |
013 [1] 13 💬 |
883 |
Gsk2395612 |
- |
- |
- |
- |
013 [1] 13 💬 |
884 |
Gtr |
- |
- |
- |
- |
013 [1] 13 💬 |
885 |
Gtr.ace |
- |
- |
- |
- |
013 [1] 13 💬 |
886 |
Guanabenz |
Guanabenz |
[1] D04375 D04375 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 [2] 2 , 13 💬 |
887 |
Gw-1000-02 |
- |
- |
- |
- |
013 [1] 13 💬 |
888 |
Gylenia |
- |
- |
- |
- |
013 [1] 13 💬 |
889 |
Gylenia 0,5 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
890 |
Gz402668 |
- |
- |
- |
- |
013 [1] 13 💬 |
891 |
Gz402673 |
- |
- |
- |
- |
013 [1] 13 💬 |
892 |
H.p. acthar gel (repository corticotropin injection) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [1] 13 💬 |
893 |
H5g1.1-mab |
- |
- |
- |
- |
013 [3] 13, 50, 62 💬 |
894 |
Hbm9161 injection |
- |
- |
- |
- |
013 [1] 13 💬 |
895 |
Helminth ova |
- |
- |
- |
- |
013 [1] 13 💬 |
896 |
Hematopoetic stem cell infusion |
- |
- |
- |
- |
013 [1] 13 💬 |
897 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [12] 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
898 |
Hidrocloruro de fingolimod |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 14 💬 |
899 |
High dose aspirin (1300 mg/day) |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
900 |
High/low sodium diet |
- |
- |
- |
- |
013 [1] 13 💬 |
901 |
Histamine |
Histamine |
[1] D08040 D08040 💬 |
HRH1 [4] HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
902 |
Histidine |
Histidine |
[1] D00032 D00032 💬 |
- |
- |
013 [3] 13, 169, 170 💬 |
903 |
Hmr 1726d |
- |
- |
- |
- |
013 [1] 13 💬 |
904 |
Hmr1726 |
- |
- |
- |
- |
013 [1] 13 💬 |
905 |
Hmr1726d |
- |
- |
- |
- |
013 [1] 13 💬 |
906 |
Hookworm larvae |
- |
- |
- |
- |
013 [1] 13 💬 |
907 |
Hp184 |
- |
- |
- |
- |
013 [1] 13 💬 |
908 |
Hul001 |
- |
- |
- |
- |
013 [1] 13 💬 |
909 |
Human anti-il-12 igg1 mab |
- |
- |
- |
- |
013 [1] 13 💬 |
910 |
Human anti-il-12 mab |
- |
- |
- |
- |
013 [1] 13 💬 |
911 |
Human anti-lingo-1 monoclonal antibody |
- |
- |
- |
- |
013 [1] 13 💬 |
912 |
Human autologous mesenchymal stem cells |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
913 |
Human fetal-derived neural stem cells (hnscs) |
- |
- |
- |
- |
013 [1] 13 💬 |
914 |
Human interferon beta |
Human interferon beta |
- |
- |
- |
013 [2] 13, 26 💬 |
915 |
Human interferon beta 1a (rebif) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
916 |
Human interferon beta-1a and glatiramer acetate |
Acetate |
[2] D04318 D04318, D04554 D04554 💬 |
HLA-A [22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNAR1, IFNAR2 💬 |
Allograft rejection [44] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
917 |
Human leucocyte interferon-alpha |
- |
- |
- |
- |
013 [1] 13 💬 |
918 |
Human monoclonal antibody (cnto 1275) to interleukin-12p40 |
- |
- |
- |
- |
013 [1] 13 💬 |
919 |
Human neural stem cells |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
920 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 [9] 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
921 |
Human recombinant growth hormone |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
013 [2] 13, 299 💬 |
922 |
Human umbilical cord mesenchymal stem cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
013 [2] 13, 113 💬 |
923 |
Humax-cd20 |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [2] 13, 46 💬 |
924 |
Hydrochlorothiazide |
Hydrochlorothiazide |
[1] D00340 D00340 💬 |
- |
- |
013 [4] 13, 67, 225, 235 💬 |
925 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 [7] 5 , 6 , 13, 17, 83, 97, 226 💬 |
926 |
Hydrogen peroxide |
Hydrogen |
[1] D00008 D00008 💬 |
- |
- |
013 [1] 13 💬 |
927 |
Hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
013 [23] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
928 |
Hydroxytyrosol |
Hydroxytyrosol |
- |
- |
- |
013 [1] 13 💬 |
929 |
Hydroxyurea |
Hydroxyurea |
[1] D00341 D00341 💬 |
RRM2 [1] RRM2 💬 |
Drug metabolism - other enzymes [6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 [8] 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
930 |
Hyperimmune caprine serum against hiv lysate |
- |
- |
- |
- |
013 [1] 13 💬 |
931 |
Ibudilast |
Ibudilast |
[1] D01385 D01385 💬 |
CYSLTR1 [8] CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR 💬 |
Apelin signaling pathway [16] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [2] 2 , 13 💬 |
932 |
Ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [6] 13, 46, 65, 113, 271, 299 💬 |
933 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
934 |
Idebenone |
Idebenone |
[1] D01750 D01750 💬 |
- |
- |
006 [5] 6 , 13, 18, 113, 302 💬 |
935 |
Ifa incomplete freund's adjuvant |
- |
- |
- |
- |
013 [1] 13 💬 |
936 |
Ifn beta 1a 44 mcg tiw |
- |
- |
- |
- |
013 [1] 13 💬 |
937 |
Ifn beta-1a |
- |
- |
- |
- |
013 [1] 13 💬 |
938 |
Ifn ß-1a |
- |
- |
- |
- |
013 [1] 13 💬 |
939 |
Ifn-beta-1a (rebif®) |
- |
- |
- |
- |
013 [1] 13 💬 |
940 |
Ifn-beta-1a, (avonex®) |
- |
- |
- |
- |
013 [1] 13 💬 |
941 |
Ifn-ß-1a (rebif®) |
- |
- |
- |
- |
013 [1] 13 💬 |
942 |
Ifn-ß-1a, (avonex®) |
- |
- |
- |
- |
013 [1] 13 💬 |
943 |
Il2 |
- |
- |
- |
- |
013 [2] 13, 60 💬 |
944 |
Imatinib |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
945 |
Imatinib mesilate |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [3] 13, 86, 88 💬 |
946 |
Imatinib mesylate |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [5] 13, 28, 34, 51, 86 💬 |
947 |
Immune globulin |
- |
- |
- |
- |
011 [3] 11, 13, 14 💬 |
948 |
Immune globulin iv [human], 10% caprylate/chromatography purified |
- |
- |
- |
- |
013 [1] 13 💬 |
949 |
Immunoglobulin |
- |
- |
- |
- |
013 [3] 13, 14, 63 💬 |
950 |
Immunoglobulin g |
- |
- |
- |
- |
011 [7] 11, 13, 14, 49, 50, 63, 65 💬 |
951 |
Immunosuppressive agents |
- |
- |
- |
- |
013 [2] 13, 50 💬 |
952 |
Impact |
- |
- |
- |
- |
006 [8] 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
953 |
Imu-838 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
954 |
Imu-838 (30 mg/day) |
- |
- |
- |
- |
013 [1] 13 💬 |
955 |
Imu-838 (45 mg/day) |
- |
- |
- |
- |
013 [1] 13 💬 |
956 |
Imurel |
- |
- |
- |
- |
013 [4] 13, 46, 96, 97 💬 |
957 |
Incabotulinumtoxina |
- |
- |
- |
- |
013 [1] 13 💬 |
958 |
Incobotulinum toxin a |
- |
- |
- |
- |
002 [3] 2 , 6 , 13 💬 |
959 |
Inebilizumab |
Inebilizumab |
[1] D11757 D11757 💬 |
CD19 [1] CD19 💬 |
B cell receptor signaling pathway [5] B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency |
011 [3] 11, 13, 300 💬 |
960 |
Inf beta-1a |
- |
- |
- |
- |
013 [1] 13 💬 |
961 |
Influenza vaccine |
- |
- |
- |
- |
011 [5] 11, 13, 46, 51, 84 💬 |
962 |
Inhaled cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
963 |
Injectable ms dmt |
- |
- |
- |
- |
013 [1] 13 💬 |
964 |
Injection of autologous stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
965 |
Injection of cell free media |
- |
- |
- |
- |
013 [1] 13 💬 |
966 |
Inn colecalciferol |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 [1] 13 💬 |
967 |
Inosine |
Inosine |
[1] D00054 D00054 💬 |
- |
- |
002 [4] 2 , 6 , 13, 17 💬 |
968 |
Insulin |
- |
- |
- |
- |
013 [5] 13, 46, 75, 78, 299 💬 |
969 |
Int131 |
- |
- |
- |
- |
013 [1] 13 💬 |
970 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 [5] 13, 20, 26, 96, 97 💬 |
971 |
Interferon beta - 1a (ifn) |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
972 |
Interferon beta -1b |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
973 |
Interferon beta 1 |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
974 |
Interferon beta 1-a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
975 |
Interferon beta 1-b (betaferon/betaseron, bay86-5046) |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
976 |
Interferon beta 1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
977 |
Interferon beta 1a 30 ug im once weekly |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
978 |
Interferon beta 1a pegilado |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
979 |
Interferon beta 1a, oral doxycycline |
Doxycycline |
[6] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D04554 D04554, D07876 D07876 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
980 |
Interferon beta 1b |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
981 |
Interferon beta 1b (betaseron, bay86-5046) |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
982 |
Interferon beta therapy |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
983 |
Interferon beta treatment to add-on atorvastatin treatment |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
984 |
Interferon beta type 1a |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
985 |
Interferon beta-1 a |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
986 |
Interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [4] 13, 26, 96, 97 💬 |
987 |
Interferon beta-1a (avonex) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
988 |
Interferon beta-1a (avonex®) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
989 |
Interferon beta-1a (current approved manufacturing process invloving fbs) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
990 |
Interferon beta-1a (new process, manufactured without fbs) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
991 |
Interferon beta-1a (rebif) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
992 |
Interferon beta-1a (rebif®) alone |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
993 |
Interferon beta-1a 30 µg |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
994 |
Interferon beta-1a fbs-free/hsa free, rnf |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
995 |
Interferon beta-1a fbs-free/hsa-free |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
996 |
Interferon beta-1a fbs-free/hsa-free, rnf |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
997 |
Interferon beta-1a hsa+ biosimilar |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
998 |
Interferon beta-1a hsa-free biosimilar |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
999 |
Interferon beta-1a original |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1000 |
Interferon beta-1a, 30 µg/0.5 ml |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1001 |
Interferon beta-1b |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1002 |
Interferon beta-1b (betaferon, bay 86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1003 |
Interferon beta-1b (betaferon, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1004 |
Interferon beta-1b (betaferon/betaseron, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1005 |
Interferon beta-1b (betaferon®, bay 86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1006 |
Interferon beta-1b (betaseron, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1007 |
Interferon beta-1b (betaseron, betaferon, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1008 |
Interferon beta-1b (pf530, betaferon) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1009 |
Interferon beta-1b and tacrolimus |
Human interferon beta |
[3] D00107 D00107, D00746 D00746, D08556 D08556 💬 |
IFNAR1 [7] IFNAR1, IFNAR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [47] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1010 |
Interferon beta-1b group |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1011 |
Interferon beta-1b, (betaseron bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1012 |
Interferon beta-1b, frp about 6 weeks after randomization |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1013 |
Interferon beta-1b, frp within 15 days after randomization |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1014 |
Interferon beta-1b/atorvastatin group |
Atorvastatin |
[4] D00258 D00258, D00746 D00746, D00887 D00887, D07474 D07474 💬 |
HMGCR [3] HMGCR, IFNAR1, IFNAR2 💬 |
AMPK signaling pathway [22] AMPK signaling pathway, Bile secretion, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1015 |
Interferon beta1a |
- |
- |
- |
- |
013 [1] 13 💬 |
1016 |
Interferon ß-1a |
- |
- |
- |
- |
013 [1] 13 💬 |
1017 |
Interferon ß-1a (avonex®) |
- |
- |
- |
- |
013 [1] 13 💬 |
1018 |
Interferon ß-1a 30 µg |
- |
- |
- |
- |
013 [1] 13 💬 |
1019 |
Interferon ß-1b |
- |
- |
- |
- |
013 [1] 13 💬 |
1020 |
Interferon-1beta (betaseron, bay86-5046) |
- |
- |
- |
- |
013 [1] 13 💬 |
1021 |
Interferon-beta |
Human interferon beta |
- |
- |
- |
013 [2] 13, 97 💬 |
1022 |
Interferon-beta (ifn-beta) |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1023 |
Interferon-beta 1a |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1024 |
Interferon-beta 1a fbs-free/hsa free, rnf |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1025 |
Interferon-beta 1a fbs-free/hsa-free, rnf |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1026 |
Interferon-beta 1b |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1027 |
Interferon-beta 1b (betaseron) |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1028 |
Interferon-beta [ifn-beta] |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1029 |
Interferon-beta and human leukocyte interferon-a |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1030 |
Interferon-beta-1 |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1031 |
Interferon-beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [2] 13, 97 💬 |
1032 |
Interferon-beta-1a (avonex) plus methylprednisolone |
Human interferon beta |
[7] D00407 D00407, D00751 D00751, D00979 D00979, D04554 D04554, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
IFNAR1 [3] IFNAR1, IFNAR2, NR3C1 💬 |
Coronavirus disease - COVID-19 [19] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1033 |
Interferon-beta-1a fbs-free/hsa free, rnf |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1034 |
Interferon-beta-1a fbs-free/hsa-free |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1035 |
Interferon-beta-1b |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1036 |
Interferon-beta-1b (betaseron, bay 86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1037 |
Interferon-beta1 |
- |
- |
- |
- |
013 [1] 13 💬 |
1038 |
Interferon-ß |
- |
- |
- |
- |
013 [1] 13 💬 |
1039 |
Interferon-ß [ifn-ß] |
- |
- |
- |
- |
013 [1] 13 💬 |
1040 |
Interferon-ß-1 |
- |
- |
- |
- |
013 [1] 13 💬 |
1041 |
Interferon-ß-1a |
- |
- |
- |
- |
013 [1] 13 💬 |
1042 |
Interferon-ß-1b |
- |
- |
- |
- |
013 [1] 13 💬 |
1043 |
Interferone |
- |
- |
- |
- |
013 [1] 13 💬 |
1044 |
Interferón beta 1a |
- |
- |
- |
- |
013 [1] 13 💬 |
1045 |
Interferón beta 1a pegilado |
- |
- |
- |
- |
013 [1] 13 💬 |
1046 |
Interferón beta-1a pegilado |
- |
- |
- |
- |
013 [1] 13 💬 |
1047 |
Intradetrusor injection of botulinum toxin-a |
- |
- |
- |
- |
013 [1] 13 💬 |
1048 |
Intratect |
- |
- |
- |
- |
013 [3] 13, 35, 65 💬 |
1049 |
Intrathecal administration of autologous msc-np |
- |
- |
- |
- |
013 [1] 13 💬 |
1050 |
Intrathecal methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 [1] 13 💬 |
1051 |
Intrathecal msc-np injection |
- |
- |
- |
- |
013 [1] 13 💬 |
1052 |
Intravenous (iv) infusions |
- |
- |
- |
- |
013 [1] 13 💬 |
1053 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 [8] 13, 14, 35, 38, 39, 49, 51, 309 💬 |
1054 |
Intravenous injection of mesenchymal stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
1055 |
Intravenous methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 145 💬 |
1056 |
Intravenous steroid |
- |
- |
- |
- |
013 [1] 13 💬 |
1057 |
Ipx056 |
- |
- |
- |
- |
013 [1] 13 💬 |
1058 |
Ipx056 10 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1059 |
Ipx056 20 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1060 |
Ipx056 30 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1061 |
Ipx056 35 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1062 |
Ipx056 40 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1063 |
Ipx056-10 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1064 |
Ipx056-20 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1065 |
Ipx056-25 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1066 |
Ipx056-30 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1067 |
Ipx056-35 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1068 |
Ipx056-40 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1069 |
Ir902 |
- |
- |
- |
- |
013 [1] 13 💬 |
1070 |
Iron oxide |
Ferric oxide |
[1] D04168 D04168 💬 |
- |
- |
013 [1] 13 💬 |
1071 |
Isentress |
- |
- |
- |
- |
013 [1] 13 💬 |
1072 |
Isoxsuprine |
Isoxsuprine |
[1] D08092 D08092 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1073 |
Isoxsuprine hydrochloride |
Isoxsuprine |
[1] D08092 D08092 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1074 |
Iv methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1075 |
Iv methylprednisolone (steroids) |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1076 |
Ivig |
Human immunoglobulin G |
- |
- |
- |
011 [8] 11, 13, 14, 17, 35, 50, 51, 65 💬 |
1077 |
Ixazomib |
Ixazomib |
[1] D10130 D10130 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
013 [3] 13, 16, 28 💬 |
1078 |
Ixazomib (ninlaro®) capsules |
Ixazomib |
[1] D10130 D10130 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
013 [1] 13 💬 |
1079 |
Jm |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1080 |
Jm-4 |
- |
- |
- |
- |
013 [1] 13 💬 |
1081 |
Kemstro |
- |
- |
- |
- |
013 [1] 13 💬 |
1082 |
Kepivance |
- |
- |
- |
- |
013 [1] 13 💬 |
1083 |
Keppra |
- |
- |
- |
- |
013 [1] 13 💬 |
1084 |
Keppra 250mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1085 |
Keppra 500mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1086 |
Keppra ® |
- |
- |
- |
- |
013 [1] 13 💬 |
1087 |
Ketamine |
Ketamine |
[2] D00711 D00711, D08098 D08098 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 [5] 13, 70, 113, 156, 215 💬 |
1088 |
Ketoconazole |
Ketoconazole |
[1] D00351 D00351 💬 |
CYP17A1 [1] CYP17A1 💬 |
Cortisol synthesis and secretion [6] Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis |
008 [3] 8 , 13, 75 💬 |
1089 |
Keyhole limpet hemocyanin |
keyhole limpet hemocyanin |
- |
- |
- |
013 [2] 13, 46 💬 |
1090 |
Keyhole limpet hemocyanin (klh) |
keyhole limpet hemocyanin |
- |
- |
- |
013 [1] 13 💬 |
1091 |
Keyhole limpet hemocyanin (klh) neo-antigen |
keyhole limpet hemocyanin |
- |
- |
- |
013 [1] 13 💬 |
1092 |
Klh |
- |
- |
- |
- |
013 [2] 13, 65 💬 |
1093 |
L acetyl carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 [1] 13 💬 |
1094 |
L-000124467 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1095 |
L-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 [6] 13, 96, 97, 265, 298, 316 💬 |
1096 |
L-histidine |
Histidine |
[1] D00032 D00032 💬 |
- |
- |
013 [1] 13 💬 |
1097 |
L01bb04 |
- |
- |
- |
- |
013 [1] 13 💬 |
1098 |
L03 ab |
- |
- |
- |
- |
013 [1] 13 💬 |
1099 |
L03 ab 08 |
- |
- |
- |
- |
013 [1] 13 💬 |
1100 |
L03 ab07 |
- |
- |
- |
- |
013 [1] 13 💬 |
1101 |
L03ab13 |
- |
- |
- |
- |
013 [1] 13 💬 |
1102 |
L04aa04 |
- |
- |
- |
- |
013 [1] 13 💬 |
1103 |
L04aa04 - immunoglobulina antitimocitaria (di coniglio) immunoglobulina di coniglio antitimociti umani thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [1] 13 💬 |
1104 |
L04aa31 |
- |
- |
- |
- |
013 [1] 13 💬 |
1105 |
La |
- |
- |
- |
- |
006 [5] 6 , 13, 75, 76, 222 💬 |
1106 |
Lactose |
Lactose |
[2] D00046 D00046, D03226 D03226 💬 |
- |
- |
002 [6] 2 , 6 , 13, 97, 228, 310 💬 |
1107 |
Lactose monohydrate |
Lactose |
[2] D00046 D00046, D03226 D03226 💬 |
- |
- |
013 [1] 13 💬 |
1108 |
Lamotrigine |
Lamotrigine |
[1] D00354 D00354 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [5] 13, 34, 38, 114, 144 💬 |
1109 |
Lamotrigine extended release tablets |
Lamotrigine |
[1] D00354 D00354 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
1110 |
Laquinimod |
Laquinimod |
- |
- |
- |
008 [4] 8 , 13, 49, 96 💬 |
1111 |
Laquinimod 0.3 |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
1112 |
Laquinimod 0.6 |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
1113 |
Laquinimod 1.2 |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
1114 |
Laquinimod capsulas 0.6 mg |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
1115 |
Laquinimod capsules 0.3 mg |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
1116 |
Laquinimod capsules 0.6 mg |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
1117 |
Laquinimod sodium (usan) |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
1118 |
Laquinimod tablets 0.3 mg |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
1119 |
Lemtrada |
- |
- |
- |
- |
013 [2] 13, 65 💬 |
1120 |
Lemtrada 12 mg konzentrat zur herstellung einer infusionslösung |
- |
- |
- |
- |
013 [1] 13 💬 |
1121 |
Lenograstim |
Lenograstim |
[1] D03247 D03247 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [7] 2 , 13, 16, 18, 19, 57, 65 💬 |
1122 |
Levetiracetam |
Levetiracetam |
[1] D00709 D00709 💬 |
SV2A [1] SV2A 💬 |
ECM-receptor interaction [1] ECM-receptor interaction |
002 [4] 2 , 4 , 6 , 13 💬 |
1123 |
Levitra |
- |
- |
- |
- |
013 [2] 13, 86 💬 |
1124 |
Levocarnil |
- |
- |
- |
- |
013 [1] 13 💬 |
1125 |
Levofolene |
Levoleucovorin |
[1] D04715 D04715 💬 |
- |
- |
013 [1] 13 💬 |
1126 |
Levofolene 4 mg 30 cpr |
Levoleucovorin |
[1] D04715 D04715 💬 |
- |
- |
013 [1] 13 💬 |
1127 |
Levonorgestrel |
Levonorgestrel |
[1] D00950 D00950 💬 |
PGR [1] PGR 💬 |
Breast cancer [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 [1] 13 💬 |
1128 |
Lfb-r603 |
- |
- |
- |
- |
013 [1] 13 💬 |
1129 |
Lfb-r603, tgtx1101 |
- |
- |
- |
- |
013 [1] 13 💬 |
1130 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
1131 |
Lidocaine patch 5% |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
1132 |
Linoleic acid |
Linoleic acid |
- |
- |
- |
013 [2] 13, 299 💬 |
1133 |
Linoleic acid/oleic acid |
Linoleic acid |
[1] D02315 D02315 💬 |
- |
- |
013 [1] 13 💬 |
1134 |
Liofen xl |
- |
- |
- |
- |
013 [1] 13 💬 |
1135 |
Liothyronine |
Liothyronine |
[2] D01011 D01011, D08128 D08128 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
013 [3] 13, 210, 212 💬 |
1136 |
Liothyronine sodium |
Liothyronine |
[2] D01011 D01011, D08128 D08128 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
013 [1] 13 💬 |
1137 |
Lipoic acid |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
002 [5] 2 , 5 , 13, 14, 20 💬 |
1138 |
Lipoic acid (la) with fish oil and la without fish oil |
Fish oil |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
013 [1] 13 💬 |
1139 |
Lipoic acid and omega-3 fatty acids |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
013 [1] 13 💬 |
1140 |
Lisdexamfetamine |
Lisdexamfetamine |
[1] D08130 D08130 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
1141 |
Lisdexamfetamine sulfate |
Lisdexamfetamine |
[1] D08130 D08130 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
1142 |
Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field |
- |
- |
- |
- |
013 [1] 13 💬 |
1143 |
Lithium carbonate |
Carbonate ion |
[1] D00801 D00801 💬 |
- |
- |
002 [6] 2 , 13, 17, 18, 19, 127 💬 |
1144 |
Live hookworm larvae |
- |
- |
- |
- |
013 [1] 13 💬 |
1145 |
Live necator americanus larvae |
- |
- |
- |
- |
013 [1] 13 💬 |
1146 |
Locally approved intravenous contrast medium for contrast enhanced mri |
- |
- |
- |
- |
013 [1] 13 💬 |
1147 |
Loperamide |
Loperamide |
[3] D00729 D00729, D07113 D07113, D08144 D08144 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 [2] 13, 97 💬 |
1148 |
Loratadine |
Loratadine |
[1] D00364 D00364 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [3] 13, 46, 98 💬 |
1149 |
Low dose arm receiving neutral oil and 400 iu/g of vitamin d every second day |
Vitamin D |
- |
- |
- |
013 [1] 13 💬 |
1150 |
Low dose aspirin (162 mg/day) |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
1151 |
Low dose cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
1152 |
Low immunogenic interferon-beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1153 |
Lubiprostone |
Lubiprostone |
[1] D04790 D04790 💬 |
CLCN2 [1] CLCN2 💬 |
Mineral absorption [1] Mineral absorption |
006 [4] 6 , 13, 290, 299 💬 |
1154 |
Lumbar puncture |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1155 |
Lutenyl |
- |
- |
- |
- |
013 [1] 13 💬 |
1156 |
Ly2127399 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
1157 |
Ly248686 |
- |
- |
- |
- |
013 [1] 13 💬 |
1158 |
Lysine |
L-Lysine |
[1] D02304 D02304 💬 |
- |
- |
013 [4] 13, 97, 228, 299 💬 |
1159 |
M2951 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
1160 |
Mabcampath |
- |
- |
- |
- |
013 [2] 13, 60 💬 |
1161 |
Mabcampath 10 mg/ml concentrado para solución para perfusión |
- |
- |
- |
- |
013 [1] 13 💬 |
1162 |
Mabcampath ® |
- |
- |
- |
- |
013 [1] 13 💬 |
1163 |
Mabcampath-1h |
- |
- |
- |
- |
013 [1] 13 💬 |
1164 |
Mabcampath® |
- |
- |
- |
- |
013 [1] 13 💬 |
1165 |
Mabthera |
- |
- |
- |
- |
011 [22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
1166 |
Mabthera (rituximab) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [4] 13, 46, 49, 53 💬 |
1167 |
Mabthera or biosimilar rituximab product |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1168 |
Mabthera® |
- |
- |
- |
- |
013 [6] 13, 35, 43, 44, 46, 93 💬 |
1169 |
Magnesium |
Magnesium |
- |
- |
- |
006 [16] 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
1170 |
Maltodextrin |
Maltodextrin |
[1] D02329 D02329 💬 |
- |
- |
006 [4] 6 , 13, 96, 97 💬 |
1171 |
Maltodextrin fiber supplement |
Maltodextrin |
[1] D02329 D02329 💬 |
- |
- |
013 [1] 13 💬 |
1172 |
Mangafodipir |
Mangafodipir |
[1] D08262 D08262 💬 |
- |
- |
013 [2] 13, 58 💬 |
1173 |
Mangafodipir (teslascan) |
Mangafodipir |
[1] D08262 D08262 💬 |
- |
- |
013 [1] 13 💬 |
1174 |
Mannose |
Mannose |
- |
- |
- |
013 [2] 13, 256 💬 |
1175 |
Mantadan*20cpr 100mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1176 |
Marijuana |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
1177 |
Masitinb mesylate |
- |
- |
- |
- |
013 [1] 13 💬 |
1178 |
Masitinib |
Masitinib |
[1] D10229 D10229 💬 |
KIT [1] KIT 💬 |
Acute myeloid leukemia [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
1179 |
Masitinib mesylate |
Masitinib |
[1] D10229 D10229 💬 |
KIT [1] KIT 💬 |
Acute myeloid leukemia [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
1180 |
Mastinib |
- |
- |
- |
- |
013 [1] 13 💬 |
1181 |
Mavenclad |
- |
- |
- |
- |
013 [1] 13 💬 |
1182 |
Mavenclad 10 mg tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
1183 |
Mavenclad tabletter 10 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1184 |
Mavenclad® |
- |
- |
- |
- |
013 [1] 13 💬 |
1185 |
Mayzent |
- |
- |
- |
- |
013 [1] 13 💬 |
1186 |
Mbp peptide |
- |
- |
- |
- |
013 [1] 13 💬 |
1187 |
Mbp8298 |
- |
- |
- |
- |
013 [1] 13 💬 |
1188 |
Mbp8298 synthetic peptide |
- |
- |
- |
- |
013 [1] 13 💬 |
1189 |
Md1003 |
- |
- |
- |
- |
002 [5] 2 , 10, 13, 14, 20 💬 |
1190 |
Md1003 100mg capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
1191 |
Medi-551 |
- |
- |
- |
- |
013 [2] 13, 51 💬 |
1192 |
Medi-551 100 mg-iv |
- |
- |
- |
- |
013 [1] 13 💬 |
1193 |
Medi-551 30 mg-iv |
- |
- |
- |
- |
013 [1] 13 💬 |
1194 |
Medi-551 300 mg-sc |
- |
- |
- |
- |
013 [1] 13 💬 |
1195 |
Medi-551 60 mg-sc |
- |
- |
- |
- |
013 [1] 13 💬 |
1196 |
Medi-551 600 mg-iv |
- |
- |
- |
- |
013 [1] 13 💬 |
1197 |
Medical marijuana |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
1198 |
Medrol |
- |
- |
- |
- |
013 [3] 13, 46, 222 💬 |
1199 |
Megadose oral methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1200 |
Melatonin |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [11] 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
1201 |
Melphalan |
Melphalan |
[1] D00369 D00369 💬 |
- |
- |
011 [15] 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
1202 |
Memantine |
Memantine |
[2] D04905 D04905, D08174 D08174 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [7] 2 , 6 , 8 , 13, 49, 127, 205 💬 |
1203 |
Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) |
- |
- |
- |
- |
013 [1] 13 💬 |
1204 |
Menitorix |
- |
- |
- |
- |
013 [1] 13 💬 |
1205 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 [11] 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
1206 |
Mesenchymal stem cells (mscs) |
- |
- |
- |
- |
013 [3] 13, 36, 96 💬 |
1207 |
Mesenchymal stem/stromal cells |
- |
- |
- |
- |
013 [1] 13 💬 |
1208 |
Mesna |
- |
- |
- |
- |
011 [11] 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
1209 |
Metex |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1210 |
Metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
1211 |
Methelphenidate |
- |
- |
- |
- |
013 [1] 13 💬 |
1212 |
Methotrexat |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 [4] 13, 46, 50, 96 💬 |
1213 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
1214 |
Methyl b12 |
- |
- |
- |
- |
013 [1] 13 💬 |
1215 |
Methyl folate |
Folic acid |
[1] D00070 D00070 💬 |
- |
- |
013 [1] 13 💬 |
1216 |
Methyl prednisolonate |
- |
- |
- |
- |
013 [1] 13 💬 |
1217 |
Methyloprednisolone |
- |
- |
- |
- |
013 [1] 13 💬 |
1218 |
Methylphenidate |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [7] 6 , 13, 34, 84, 113, 179, 206 💬 |
1219 |
Methylphenidate hydrochloride |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [2] 6 , 13 💬 |
1220 |
Methylphenidate modified release |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
1221 |
Methylphenidate modified release 20 mg |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
1222 |
Methylphenidate modified release 30 mg |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
1223 |
Methylphenidate modified release 40 mg |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
013 [1] 13 💬 |
1224 |
Methylprednisolon |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [4] 13, 14, 51, 66 💬 |
1225 |
Methylprednisolon-21-hydrogensuccinat, natriumsalz |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1226 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
1227 |
Methylprednisolone (drug) |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1228 |
Methylprednisolone 1250 mg/24h x3 days |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1229 |
Methylprednisolone hemisuccinate |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1230 |
Methylprednisolone iv |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1231 |
Methylprednisolone po |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1232 |
Methylprednisolone sodium hemisuccinate |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
1233 |
Methylprednisolone sodium succinate |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [6] 13, 46, 49, 50, 51, 211 💬 |
1234 |
Metilprednisolone sodio succinato |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
1235 |
Mg |
- |
- |
- |
- |
006 [3] 6 , 13, 51 💬 |
1236 |
Microgynon |
- |
- |
- |
- |
013 [2] 13, 51 💬 |
1237 |
Microgynon® |
- |
- |
- |
- |
013 [1] 13 💬 |
1238 |
Micropirin |
- |
- |
- |
- |
013 [1] 13 💬 |
1239 |
Midazolam |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
1240 |
Mild dose cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
1241 |
Mineral boost (magnesium) |
Magnesium |
- |
- |
- |
013 [1] 13 💬 |
1242 |
Minocycline |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
002 [13] 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
1243 |
Minocycline 100 mg film-coated tablets |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
013 [1] 13 💬 |
1244 |
Minocycline 100mg |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
013 [1] 13 💬 |
1245 |
Minocycline hydrochloride |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
013 [4] 13, 201, 206, 299 💬 |
1246 |
Mirabegron |
Mirabegron |
[1] D09535 D09535 💬 |
ADRB3 [1] ADRB3 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway |
006 [3] 6 , 13, 226 💬 |
1247 |
Mis416 |
- |
- |
- |
- |
013 [1] 13 💬 |
1248 |
Mitoq |
- |
- |
- |
- |
006 [3] 6 , 13, 97 💬 |
1249 |
Mitoquinone |
Mitoquinone |
- |
- |
- |
013 [1] 13 💬 |
1250 |
Mitoxantrone |
Mitoxantrone |
[2] D02166 D02166, D08224 D08224 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
1251 |
Mk0812 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1252 |
Mln1202 |
- |
- |
- |
- |
013 [1] 13 💬 |
1253 |
Mmf |
- |
- |
- |
- |
013 [13] 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
1254 |
Modafinil |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [4] 6 , 13, 49, 93 💬 |
1255 |
Mog peptide |
- |
- |
- |
- |
013 [1] 13 💬 |
1256 |
Monitor |
Methamidophos |
- |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
1257 |
Monoclonal antibody m-t412 |
- |
- |
- |
- |
013 [1] 13 💬 |
1258 |
Monomethyl fumarate |
Monomethyl fumarate |
[1] D11492 D11492 💬 |
- |
- |
013 [1] 13 💬 |
1259 |
Monomethyl fumarate 190 mg |
Monomethyl fumarate |
[1] D11492 D11492 💬 |
- |
- |
013 [1] 13 💬 |
1260 |
Montelukast |
Montelukast |
[2] D00529 D00529, D08229 D08229 💬 |
CYSLTR1 [1] CYSLTR1 💬 |
Calcium signaling pathway [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction |
013 [5] 13, 46, 85, 98, 228 💬 |
1261 |
Mor103 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1262 |
Msc2015 |
- |
- |
- |
- |
013 [1] 13 💬 |
1263 |
Msc2304479a |
- |
- |
- |
- |
013 [1] 13 💬 |
1264 |
Msc2304480a |
- |
- |
- |
- |
013 [1] 13 💬 |
1265 |
Msc2304481a |
- |
- |
- |
- |
013 [1] 13 💬 |
1266 |
Msc2304482a |
- |
- |
- |
- |
013 [1] 13 💬 |
1267 |
Msc2358825a |
- |
- |
- |
- |
013 [1] 13 💬 |
1268 |
Msc2364447c |
- |
- |
- |
- |
013 [2] 13, 49 💬 |
1269 |
Msc2430913a or ono-4641 (to be used as synonyms) |
- |
- |
- |
- |
013 [1] 13 💬 |
1270 |
Msc2491529a |
- |
- |
- |
- |
013 [1] 13 💬 |
1271 |
Msdmds other than betaseron (interferon beta-1b, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1272 |
Mstc-001 (ms-stat) |
- |
- |
- |
- |
013 [1] 13 💬 |
1273 |
Mt-1303 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
1274 |
Mt-1303 [0.1] |
- |
- |
- |
- |
013 [1] 13 💬 |
1275 |
Mt-1303 [0.2] |
- |
- |
- |
- |
013 [1] 13 💬 |
1276 |
Mt-1303 [0.4] |
- |
- |
- |
- |
013 [1] 13 💬 |
1277 |
Mt-1303-forma |
- |
- |
- |
- |
013 [1] 13 💬 |
1278 |
Mt-1303-formb |
- |
- |
- |
- |
013 [1] 13 💬 |
1279 |
Mt-1303-high |
- |
- |
- |
- |
013 [1] 13 💬 |
1280 |
Mt-1303-low |
- |
- |
- |
- |
013 [1] 13 💬 |
1281 |
Mt-1303-middle |
- |
- |
- |
- |
013 [1] 13 💬 |
1282 |
Multiferon |
- |
- |
- |
- |
013 [1] 13 💬 |
1283 |
Multiple (4 autologous subcutaneous t cell vaccinations with t cell lines reactive to nine myelin peptides) |
- |
- |
- |
- |
013 [1] 13 💬 |
1284 |
Mutagrip |
- |
- |
- |
- |
011 [2] 11, 13 💬 |
1285 |
Mycophenolate |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
1286 |
Mycophenolate mofetil |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
1287 |
Mycophenolate mofetil (cellcept) |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 [2] 11, 13 💬 |
1288 |
Mycophenolate mofetil (mmf) |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
013 [7] 13, 49, 51, 60, 65, 66, 222 💬 |
1289 |
Méthylprednisolone |
- |
- |
- |
- |
013 [1] 13 💬 |
1290 |
Méthylprednisolone mylan |
- |
- |
- |
- |
013 [1] 13 💬 |
1291 |
N acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
013 [1] 13 💬 |
1292 |
N-acetyl cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
013 [7] 13, 19, 34, 85, 88, 296, 310 💬 |
1293 |
N-acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [10] 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
1294 |
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
- |
- |
- |
- |
013 [1] 13 💬 |
1295 |
N.a. |
- |
- |
- |
- |
003 [10] 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
1296 |
N02bg10 |
- |
- |
- |
- |
013 [1] 13 💬 |
1297 |
N03ax12 |
- |
- |
- |
- |
013 [1] 13 💬 |
1298 |
N06dx01 |
- |
- |
- |
- |
013 [1] 13 💬 |
1299 |
Nabilone |
Nabilone |
[1] D05099 D05099 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [2] 6 , 13 💬 |
1300 |
Nabiximols |
Nabiximols |
[1] D09317 D09317 💬 |
- |
- |
013 [1] 13 💬 |
1301 |
Nabiximols - sativex |
Nabiximols |
[1] D09317 D09317 💬 |
- |
- |
013 [1] 13 💬 |
1302 |
Naltrexone |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [12] 6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 |
1303 |
Namisol |
- |
- |
- |
- |
013 [2] 13, 298 💬 |
1304 |
Nanocort |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
1305 |
Nanocurcumin |
- |
- |
- |
- |
013 [2] 13, 271 💬 |
1306 |
Naproxen |
Naproxen |
[1] D00118 D00118 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [3] 13, 46, 271 💬 |
1307 |
Natalizumab |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [4] 13, 15, 46, 96 💬 |
1308 |
Natalizumab (bg00002) |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1309 |
Natalizumab (ntz) |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1310 |
Natalizumab (tysabri) |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1311 |
Natalizumab for iv infusion |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1312 |
Natalizumab for subcutaneous injection |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1313 |
Natalizumab injection [tysabri] |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1314 |
Natalizumab iv |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1315 |
Natalizumab sc |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1316 |
Natalizumab treatment |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1317 |
Nbi-5788 |
- |
- |
- |
- |
013 [1] 13 💬 |
1318 |
Nbt-nm108 (60 g/day) |
- |
- |
- |
- |
013 [1] 13 💬 |
1319 |
Nd |
- |
- |
- |
- |
013 [4] 13, 46, 51, 97 💬 |
1320 |
Nebido |
- |
- |
- |
- |
013 [1] 13 💬 |
1321 |
Nebido® testosterone undecanoate 1000 mg/4 ml solution for injection |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 [1] 13 💬 |
1322 |
Necator americanus |
- |
- |
- |
- |
013 [1] 13 💬 |
1323 |
Neorecormon |
- |
- |
- |
- |
013 [2] 13, 18 💬 |
1324 |
Neramexane |
Neramexane |
- |
- |
- |
013 [1] 13 💬 |
1325 |
Neramexane mesylate |
Neramexane |
- |
- |
- |
013 [1] 13 💬 |
1326 |
Nerispirdine |
Nerispirdine |
- |
- |
- |
013 [1] 13 💬 |
1327 |
Nerispirdine (hp184) |
Nerispirdine |
- |
- |
- |
013 [1] 13 💬 |
1328 |
Nerispirdine hydrochloride |
Nerispirdine |
- |
- |
- |
013 [1] 13 💬 |
1329 |
Neupogen |
- |
- |
- |
- |
013 [4] 13, 28, 51, 285 💬 |
1330 |
Neuroaspis plp10® |
- |
- |
- |
- |
013 [1] 13 💬 |
1331 |
Neurontin |
- |
- |
- |
- |
013 [1] 13 💬 |
1332 |
Neurontin 300 mg hard capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
1333 |
Neurovax |
- |
- |
- |
- |
013 [1] 13 💬 |
1334 |
Neurovax 300ug/ml dose for im injection |
- |
- |
- |
- |
013 [1] 13 💬 |
1335 |
New formulation of rebif - human interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1336 |
Niacinamide |
Nicotinamide |
[1] D00036 D00036 💬 |
- |
- |
005 [4] 5 , 6 , 13, 67 💬 |
1337 |
Ninlaro |
- |
- |
- |
- |
013 [2] 13, 61 💬 |
1338 |
Nitrofurantoin |
Nitrofurantoin |
[1] D00439 D00439 💬 |
- |
- |
013 [1] 13 💬 |
1339 |
Nivolumab |
Nivolumab |
[1] D10316 D10316 💬 |
PDCD1 [1] PDCD1 💬 |
Cell adhesion molecules [3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
1340 |
Nomegestrol |
Nomegestrol |
[1] D07222 D07222 💬 |
PGR [1] PGR 💬 |
Breast cancer [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 [1] 13 💬 |
1341 |
Nomegestrol acetate |
Acetate |
[2] D07222 D07222, D08281 D08281 💬 |
PGR [1] PGR 💬 |
Breast cancer [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 [1] 13 💬 |
1342 |
Non-pegylated interferon |
- |
- |
- |
- |
013 [1] 13 💬 |
1343 |
Norethindrone |
Norethisterone |
[2] D00182 D00182, D00953 D00953 💬 |
PGR [1] PGR 💬 |
Breast cancer [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
013 [4] 13, 46, 49, 299 💬 |
1344 |
Normal saline for injection |
- |
- |
- |
- |
013 [1] 13 💬 |
1345 |
Novantrone |
- |
- |
- |
- |
013 [1] 13 💬 |
1346 |
Novantrone*inf 2mg/ml 5ml |
- |
- |
- |
- |
013 [1] 13 💬 |
1347 |
Novartis pharmaceuticals corporation |
- |
- |
- |
- |
013 [1] 13 💬 |
1348 |
Novatrex |
- |
- |
- |
- |
013 [1] 13 💬 |
1349 |
Npb-01 |
- |
- |
- |
- |
013 [3] 13, 14, 162 💬 |
1350 |
Nt-ko-003 |
- |
- |
- |
- |
013 [1] 13 💬 |
1351 |
Nu100 |
- |
- |
- |
- |
013 [1] 13 💬 |
1352 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
1353 |
Nurown (msc-ntf cells) |
- |
- |
- |
- |
013 [1] 13 💬 |
1354 |
Nvf233 |
- |
- |
- |
- |
013 [1] 13 💬 |
1355 |
Och-ncnp1 |
- |
- |
- |
- |
013 [1] 13 💬 |
1356 |
Oclelizumab |
- |
- |
- |
- |
013 [1] 13 💬 |
1357 |
Ocr |
- |
- |
- |
- |
013 [1] 13 💬 |
1358 |
Ocrelizumab |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [3] 13, 46, 49 💬 |
1359 |
Ocrelizumab 300 mg |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1360 |
Ocrelizumab 300mg |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1361 |
Ocrelizumab 300mg /10ml |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1362 |
Ocrelizumab 300mg/10 ml |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1363 |
Ocrelizumab 300mg/10ml |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1364 |
Ocrelizumab 600 mg |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1365 |
Ocrelizumab at home |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1366 |
Ocrelizumab dose 1 |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1367 |
Ocrelizumab dose 2 and dose 3 |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1368 |
Ocrevus |
- |
- |
- |
- |
013 [1] 13 💬 |
1369 |
Ocrrelizumab 300 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1370 |
Octagam |
- |
- |
- |
- |
013 [2] 13, 65 💬 |
1371 |
Octagam 5% |
- |
- |
- |
- |
013 [2] 13, 65 💬 |
1372 |
Octagam 50 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
1373 |
Ofatumumab |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [3] 13, 35, 46 💬 |
1374 |
Ofatumumab 100 |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1375 |
Ofatumumab 300 |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1376 |
Ofatumumab 30mg |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1377 |
Ofatumumab 3mg |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1378 |
Ofatumumab 60mg |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1379 |
Ofatumumab 700 |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1380 |
Ofatumumab subcutaneous injection |
Ofatumumab |
[1] D09314 D09314 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1381 |
Oleic acid |
Oleic Acid |
[1] D02315 D02315 💬 |
- |
- |
013 [2] 13, 299 💬 |
1382 |
Oleovit d3 14.400 iu/ml oral drops, solution |
- |
- |
- |
- |
013 [1] 13 💬 |
1383 |
Olesoxime (tro19622) |
TRO19622 |
- |
- |
- |
013 [1] 13 💬 |
1384 |
Olive |
Olea europaea leaf |
- |
- |
- |
013 [3] 13, 49, 53 💬 |
1385 |
Olive oil |
Olea europaea leaf |
[1] D03311 D03311 💬 |
- |
- |
013 [3] 13, 49, 53 💬 |
1386 |
Omb157 |
- |
- |
- |
- |
013 [1] 13 💬 |
1387 |
Omb157g |
- |
- |
- |
- |
013 [1] 13 💬 |
1388 |
Omega 3 |
- |
- |
- |
- |
013 [2] 13, 299 💬 |
1389 |
Omega 3 fatty acids |
Omega-3 fatty acids |
- |
- |
- |
013 [1] 13 💬 |
1390 |
Omega-3 |
Omega-3 fatty acids |
- |
- |
- |
013 [7] 13, 46, 49, 66, 79, 96, 299 💬 |
1391 |
Omega-3 fatty acids |
Omega-3 fatty acids |
- |
- |
- |
013 [2] 13, 79 💬 |
1392 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
1393 |
Onabotulinumtoxina |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
006 [3] 6 , 13, 226 💬 |
1394 |
Ono-4641 |
- |
- |
- |
- |
013 [1] 13 💬 |
1395 |
Ono-4641/ msc2430913a |
- |
- |
- |
- |
013 [1] 13 💬 |
1396 |
Ono-4641/msc2430913a |
- |
- |
- |
- |
013 [1] 13 💬 |
1397 |
Opicinumab |
Opicinumab |
[1] D11767 D11767 💬 |
- |
- |
013 [1] 13 💬 |
1398 |
Oral corticosteroids |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
1399 |
Oral lipoic acid (la) |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
013 [1] 13 💬 |
1400 |
Oral methylprednisolone 625 mg/24h x3 days |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1401 |
Oral thc |
- |
- |
- |
- |
013 [1] 13 💬 |
1402 |
Ory2001 |
- |
- |
- |
- |
013 [1] 13 💬 |
1403 |
Os440 |
- |
- |
- |
- |
013 [1] 13 💬 |
1404 |
Other analgesics and antipyretics |
- |
- |
- |
- |
013 [1] 13 💬 |
1405 |
Other disease-modifying therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
1406 |
Other h1 antagonist |
- |
- |
- |
- |
013 [1] 13 💬 |
1407 |
Other nervous system drugs |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1408 |
Other: anxiety |
- |
- |
- |
- |
013 [1] 13 💬 |
1409 |
Other: balance |
Isoxaflutole |
- |
- |
- |
006 [3] 6 , 13, 299 💬 |
1410 |
Other: balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1411 |
Other: balance trainer balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1412 |
Other: balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
1413 |
Other: berg balance scale |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
1414 |
Other: caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1415 |
Other: cardiopulmonary evaluation |
- |
- |
- |
- |
013 [1] 13 💬 |
1416 |
Other: cawthorne cooksey exercises |
- |
- |
- |
- |
013 [1] 13 💬 |
1417 |
Other: classic, progressive endurance training |
- |
- |
- |
- |
013 [1] 13 💬 |
1418 |
Other: coduse balance training and step square exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1419 |
Other: conventional balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1420 |
Other: core stability |
- |
- |
- |
- |
013 [1] 13 💬 |
1421 |
Other: determination of calcium intake by a dietician interview |
Calcium |
- |
- |
- |
013 [2] 13, 46 💬 |
1422 |
Other: dmt withdrawal |
- |
- |
- |
- |
013 [1] 13 💬 |
1423 |
Other: dual task performance |
- |
- |
- |
- |
013 [1] 13 💬 |
1424 |
Other: dynamic balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1425 |
Other: evaluation of degree chronic fatigue. |
- |
- |
- |
- |
013 [1] 13 💬 |
1426 |
Other: exercise intervention |
- |
- |
- |
- |
013 [2] 13, 18 💬 |
1427 |
Other: fatigue |
- |
- |
- |
- |
013 [1] 13 💬 |
1428 |
Other: fear of falling |
- |
- |
- |
- |
013 [1] 13 💬 |
1429 |
Other: fingolimod |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1430 |
Other: four square step test |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1431 |
Other: functional mobility |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1432 |
Other: functional reach test |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1433 |
Other: group balance training |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1434 |
Other: histamine |
Histamine |
[1] D08040 D08040 💬 |
HRH1 [4] HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 [1] 13 💬 |
1435 |
Other: hydrogen peroxide |
Hydrogen |
[1] D00008 D00008 💬 |
- |
- |
013 [1] 13 💬 |
1436 |
Other: imaging |
- |
- |
- |
- |
013 [1] 13 💬 |
1437 |
Other: incontinence severity |
- |
- |
- |
- |
013 [1] 13 💬 |
1438 |
Other: intrathecal saline injection |
- |
- |
- |
- |
013 [1] 13 💬 |
1439 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
1440 |
Other: liberation therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
1441 |
Other: mitoxantrone - immunomodulator |
Mitoxantrone |
[2] D02166 D02166, D08224 D08224 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
1442 |
Other: modified paleolithic diet |
- |
- |
- |
- |
013 [1] 13 💬 |
1443 |
Other: mybetaapp |
- |
- |
- |
- |
013 [1] 13 💬 |
1444 |
Other: natalizumab |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1445 |
Other: natalizumab discontinuation |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1446 |
Other: nbt-nm108 (0 g/day) |
- |
- |
- |
- |
013 [1] 13 💬 |
1447 |
Other: neuromuscular evaluation |
- |
- |
- |
- |
013 [1] 13 💬 |
1448 |
Other: nintendo wii fit balance exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1449 |
Other: no device |
- |
- |
- |
- |
013 [1] 13 💬 |
1450 |
Other: no msdmds therapy (control) |
- |
- |
- |
- |
013 [1] 13 💬 |
1451 |
Other: no treatment arm |
- |
- |
- |
- |
013 [1] 13 💬 |
1452 |
Other: non impact aerobics |
- |
- |
- |
- |
013 [1] 13 💬 |
1453 |
Other: normal saline |
- |
- |
- |
- |
013 [4] 13, 222, 226, 280 💬 |
1454 |
Other: observation of ocrelizumab as treatment in rrms patients |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1455 |
Other: observational control |
- |
- |
- |
- |
013 [1] 13 💬 |
1456 |
Other: one-leg stance test |
- |
- |
- |
- |
013 [1] 13 💬 |
1457 |
Other: other: disease modifying therapies (dmt) |
- |
- |
- |
- |
013 [1] 13 💬 |
1458 |
Other: pain |
- |
- |
- |
- |
013 [1] 13 💬 |
1459 |
Other: passive : lecture series |
- |
- |
- |
- |
013 [1] 13 💬 |
1460 |
Other: peak |
- |
- |
- |
- |
013 [1] 13 💬 |
1461 |
Other: peanut butter |
Peanut |
- |
- |
- |
013 [1] 13 💬 |
1462 |
Other: periodized exercise training |
- |
- |
- |
- |
013 [1] 13 💬 |
1463 |
Other: plasticity-based computerized cognitive remediation program |
- |
- |
- |
- |
013 [1] 13 💬 |
1464 |
Other: pnf |
- |
- |
- |
- |
013 [1] 13 💬 |
1465 |
Other: position sense |
- |
- |
- |
- |
013 [1] 13 💬 |
1466 |
Other: progressive exercise |
- |
- |
- |
- |
013 [1] 13 💬 |
1467 |
Other: propensity score |
- |
- |
- |
- |
013 [1] 13 💬 |
1468 |
Other: psp |
- |
- |
- |
- |
013 [1] 13 💬 |
1469 |
Other: qalcimum questionnaire |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1470 |
Other: questionnaires |
- |
- |
- |
- |
006 [5] 6 , 13, 41, 93, 96 💬 |
1471 |
Other: rhythmic auditory stimulation (ras) |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1472 |
Other: specifically design 6 month resistance training program |
- |
- |
- |
- |
013 [1] 13 💬 |
1473 |
Other: spinning grp |
- |
- |
- |
- |
013 [1] 13 💬 |
1474 |
Other: standard of care |
- |
- |
- |
- |
013 [7] 13, 49, 64, 85, 96, 245, 246 💬 |
1475 |
Other: static balance test |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1476 |
Other: strength training |
- |
- |
- |
- |
013 [1] 13 💬 |
1477 |
Other: supervised physical therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
1478 |
Other: timed up an go test |
- |
- |
- |
- |
013 [1] 13 💬 |
1479 |
Other: training groupe |
- |
- |
- |
- |
013 [1] 13 💬 |
1480 |
Other: trunk impairment |
- |
- |
- |
- |
013 [1] 13 💬 |
1481 |
Other: trunk position sense |
- |
- |
- |
- |
013 [1] 13 💬 |
1482 |
Other: uspio mri - gadolinium mri |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
1483 |
Other: vestibular habituation exercises |
- |
- |
- |
- |
013 [1] 13 💬 |
1484 |
Other: vestibular rehabilitation: balance and eye movement exercises |
Isoxaflutole |
- |
- |
- |
013 [1] 13 💬 |
1485 |
Other: virtual reality group |
- |
- |
- |
- |
013 [1] 13 💬 |
1486 |
Other: vitamin k |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [1] 13 💬 |
1487 |
Other: vitamin k cream |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [1] 13 💬 |
1488 |
Other: withdrawal of dalfampridine-er 10mg |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
1489 |
Ovastat |
Treosulfan |
[1] D07253 D07253 💬 |
- |
- |
013 [2] 13, 65 💬 |
1490 |
Ovastat 1000 |
Treosulfan |
[1] D07253 D07253 💬 |
- |
- |
013 [2] 13, 65 💬 |
1491 |
Ovastat 5000 |
Treosulfan |
[1] D07253 D07253 💬 |
- |
- |
013 [2] 13, 65 💬 |
1492 |
Oxcarbazepine |
Oxcarbazepine |
[1] D00533 D00533 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
1493 |
Oxine |
Oxyquinoline |
[1] D05321 D05321 💬 |
- |
- |
013 [1] 13 💬 |
1494 |
Oxybutynin |
Oxybutynin |
[2] D00465 D00465, D00722 D00722 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 13 💬 |
1495 |
Oxybutynin hydrochloride |
Oxybutynin |
[2] D00465 D00465, D00722 D00722 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 13 💬 |
1496 |
Oxycodone |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [7] 6 , 13, 46, 70, 226, 231, 298 💬 |
1497 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
1498 |
Ozanimod |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [3] 13, 96, 97 💬 |
1499 |
Ozanimod 0.5 mg |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1500 |
Ozanimod 1 mg |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1501 |
Ozanimod hci |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1502 |
Ozanimod hcl |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1503 |
Ozanimod hydrochloride |
Ozanimod |
[1] D10968 D10968 💬 |
S1PR1 [5] S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [3] 13, 96, 97 💬 |
1504 |
Palifermin |
Palifermin |
[1] D05338 D05338 💬 |
FGFR2 [1] FGFR2 💬 |
Calcium signaling pathway [13] Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells |
013 [4] 13, 38, 39, 65 💬 |
1505 |
Pantoprazole |
Pantoprazole |
[2] D02593 D02593, D05353 D05353 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 [2] 13, 65 💬 |
1506 |
Paracetamol |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 [5] 3 , 6 , 13, 35, 46 💬 |
1507 |
Paracetamolo 500 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1508 |
Paroxetine |
Paroxetine |
[4] D02260 D02260, D02362 D02362, D05374 D05374, D05375 D05375 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [3] 6 , 13, 46 💬 |
1509 |
Part a: 100 mg/ml gsk2618960 |
- |
- |
- |
- |
013 [1] 13 💬 |
1510 |
Part b: dose of gsk2618960 decided from part a |
- |
- |
- |
- |
013 [1] 13 💬 |
1511 |
Part c: dose of gsk2618960 decided from part a and b |
- |
- |
- |
- |
013 [1] 13 💬 |
1512 |
Pas |
- |
- |
- |
- |
013 [1] 13 💬 |
1513 |
Pat |
- |
- |
- |
- |
006 [3] 6 , 13, 160 💬 |
1514 |
Pb006 |
- |
- |
- |
- |
013 [1] 13 💬 |
1515 |
Pcv |
- |
- |
- |
- |
013 [1] 13 💬 |
1516 |
Peanut |
Peanut |
- |
- |
- |
013 [1] 13 💬 |
1517 |
Peg |
- |
- |
- |
- |
006 [9] 6 , 13, 46, 65, 78, 96, 97, 240, 299 💬 |
1518 |
Peg-liposomal prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
1519 |
Peginterferon beta-1a |
Peginterferon beta-1a |
[1] D10483 D10483 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1520 |
Pegylated intereron beta-1a |
- |
- |
- |
- |
013 [1] 13 💬 |
1521 |
Pegylated interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1522 |
Pending |
- |
- |
- |
- |
013 [6] 13, 19, 96, 97, 113, 302 💬 |
1523 |
Personalized extended interval dosing of natalizumab |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1524 |
Pet with 11c-flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 [1] 13 💬 |
1525 |
Pf-06342674 0.25 mg/kg |
- |
- |
- |
- |
013 [1] 13 💬 |
1526 |
Pf-06342674 1.5 mg/kg |
- |
- |
- |
- |
013 [1] 13 💬 |
1527 |
Pf-06342674 6.0 mg/kg |
- |
- |
- |
- |
013 [1] 13 💬 |
1528 |
Phenylcyclopropylamine derivatives and dual lsd1/mao-b (lysine-specific demethylase 1 and monoamine oxidase-b) inhibitor |
L-Lysine |
[1] D02304 D02304 💬 |
- |
- |
013 [1] 13 💬 |
1529 |
Phenytoin |
Phenytoin |
[2] D00512 D00512, D02103 D02103 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
1530 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
1531 |
Pi-2301 |
- |
- |
- |
- |
013 [1] 13 💬 |
1532 |
Pioglitazone |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
1533 |
Pixantrone |
Pixantrone |
[1] D05522 D05522 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
011 [2] 11, 13 💬 |
1534 |
Pl 04515/0127 |
- |
- |
- |
- |
013 [1] 13 💬 |
1535 |
Pl 12762/0049 |
- |
- |
- |
- |
013 [1] 13 💬 |
1536 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
1537 |
Platelet transfusion |
- |
- |
- |
- |
013 [1] 13 💬 |
1538 |
Platform |
- |
- |
- |
- |
013 [1] 13 💬 |
1539 |
Pledigry |
- |
- |
- |
- |
013 [1] 13 💬 |
1540 |
Plegridy |
- |
- |
- |
- |
013 [1] 13 💬 |
1541 |
Plegridy (peginterferon beta-1a), biogen idec ltd |
Peginterferon beta-1a |
[1] D10483 D10483 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1542 |
Plegridy - 125 mcg - soluzione iniettabile - uso sottocutaneo - penna preriempita - 0,5 ml - 6 penne preriempite |
- |
- |
- |
- |
013 [1] 13 💬 |
1543 |
Plegridy 125 micrograms |
- |
- |
- |
- |
013 [1] 13 💬 |
1544 |
Plegridy 63 micrograms |
- |
- |
- |
- |
013 [1] 13 💬 |
1545 |
Pleneva tm bgc20-0134 |
- |
- |
- |
- |
013 [1] 13 💬 |
1546 |
Plovamer acetate |
Acetate |
- |
- |
- |
013 [1] 13 💬 |
1547 |
Plovamer acetate 0.5 milligram (mg) |
Acetate |
- |
- |
- |
013 [1] 13 💬 |
1548 |
Plovamer acetate 10 mg |
Acetate |
- |
- |
- |
013 [1] 13 💬 |
1549 |
Plovamer acetate 20 mg |
Acetate |
- |
- |
- |
013 [1] 13 💬 |
1550 |
Plovamer acetate 3 mg |
Acetate |
- |
- |
- |
013 [1] 13 💬 |
1551 |
Plp |
- |
- |
- |
- |
013 [1] 13 💬 |
1552 |
Plp peptide |
- |
- |
- |
- |
013 [1] 13 💬 |
1553 |
Pneumovax ii |
- |
- |
- |
- |
013 [1] 13 💬 |
1554 |
Pnu-215062 sodium salt |
- |
- |
- |
- |
013 [1] 13 💬 |
1555 |
Po |
- |
- |
- |
- |
013 [1] 13 💬 |
1556 |
Polyphenon e |
- |
- |
- |
- |
013 [2] 13, 36 💬 |
1557 |
Ponesimod |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1558 |
Ponesimod 10 mg |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1559 |
Ponesimod 20 mg |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1560 |
Ponesimod 40 mg |
Ponesimod |
[1] D11215 D11215 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [1] 13 💬 |
1561 |
Pravastatin |
Pravastatin |
[2] D00893 D00893, D08410 D08410 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [9] 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
1562 |
Prd806998 |
- |
- |
- |
- |
013 [1] 13 💬 |
1563 |
Prebiotics (prebiotin prebiotic fiber stick pac) |
- |
- |
- |
- |
013 [1] 13 💬 |
1564 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
1565 |
Prednisolone sodium phosphate |
Phosphate ion |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [2] 13, 97 💬 |
1566 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
1567 |
Pregabalin |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 [5] 13, 36, 46, 70, 298 💬 |
1568 |
Prepulsid |
- |
- |
- |
- |
013 [1] 13 💬 |
1569 |
Prn2246 |
- |
- |
- |
- |
013 [1] 13 💬 |
1570 |
Probiotics (visbiome®) |
- |
- |
- |
- |
013 [1] 13 💬 |
1571 |
Procedure: alcohol wipes vs. no alcohol wipes |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 [1] 13 💬 |
1572 |
Procedure: autologous bone marrow transplantation |
- |
- |
- |
- |
013 [2] 13, 28 💬 |
1573 |
Procedure: autologous hematopoietic stem cell transplant |
- |
- |
- |
- |
013 [1] 13 💬 |
1574 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [6] 11, 13, 14, 28, 49, 51 💬 |
1575 |
Procedure: autologous stem cell transplantation |
- |
- |
- |
- |
013 [2] 13, 28 💬 |
1576 |
Procedure: dynamic contrast-enhanced magnetic resonance imaging |
- |
- |
- |
- |
013 [1] 13 💬 |
1577 |
Procedure: exergame |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1578 |
Procedure: fecal microbiota transplantation (fmt) of fmp30 donor stool |
- |
- |
- |
- |
013 [1] 13 💬 |
1579 |
Procedure: hematopoietic stem cell therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
1580 |
Procedure: hematopoietic stem cell transplantation |
- |
- |
- |
- |
013 [3] 13, 65, 285 💬 |
1581 |
Procedure: hematopoietic stem cell transplantation (hsct) |
- |
- |
- |
- |
013 [1] 13 💬 |
1582 |
Procedure: home based balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
1583 |
Procedure: immunoadsorption |
- |
- |
- |
- |
013 [1] 13 💬 |
1584 |
Procedure: irradiation |
- |
- |
- |
- |
013 [1] 13 💬 |
1585 |
Procedure: lumbar puncture |
- |
- |
- |
- |
006 [5] 6 , 13, 19, 96, 97 💬 |
1586 |
Procedure: mri |
- |
- |
- |
- |
013 [2] 13, 78 💬 |
1587 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 [11] 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
1588 |
Procedure: plasma exchange |
- |
- |
- |
- |
013 [5] 13, 43, 44, 64, 222 💬 |
1589 |
Procedure: radiation therapy |
- |
- |
- |
- |
013 [3] 13, 284, 285 💬 |
1590 |
Procedure: syngeneic bone marrow transplantation |
- |
- |
- |
- |
011 [3] 11, 13, 14 💬 |
1591 |
Procedure: warm compress prior to injection of glatiramer acetate |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
1592 |
Prohance (gadoteridol) |
Gadoteridol |
[1] D01137 D01137 💬 |
- |
- |
013 [1] 13 💬 |
1593 |
Prolonged-release fampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
1594 |
Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis a, hepatitis b, tick-borne encephalitis, meningococcal, pneumococcal) |
- |
- |
- |
- |
013 [1] 13 💬 |
1595 |
Provigil |
- |
- |
- |
- |
013 [1] 13 💬 |
1596 |
Provigil (modafinil) |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
013 [1] 13 💬 |
1597 |
Prucalopride |
Prucalopride |
[1] D09205 D09205 💬 |
HTR4 [1] HTR4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
013 [3] 13, 51, 96 💬 |
1598 |
Ptl201 |
- |
- |
- |
- |
013 [1] 13 💬 |
1599 |
Pv |
- |
- |
- |
- |
013 [3] 13, 97, 215 💬 |
1600 |
Quadrivalent influenza vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
1601 |
Quality of life |
- |
- |
- |
- |
013 [1] 13 💬 |
1602 |
Quetiapine |
Quetiapine |
[2] D00458 D00458, D08456 D08456 💬 |
DRD2 [2] DRD2, HTR2A 💬 |
Alcoholism [11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
006 [2] 6 , 13 💬 |
1603 |
Quinidina |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
1604 |
Quinidina sulfato |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
1605 |
Quinidine |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 [3] 2 , 8 , 13 💬 |
1606 |
Quinidine sulfate |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
1607 |
R lipoic acid |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
013 [1] 13 💬 |
1608 |
Rabbit |
Rabbit |
- |
- |
- |
011 [8] 11, 13, 49, 51, 60, 65, 96, 285 💬 |
1609 |
Rabbit anti-human thymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [2] 13, 96 💬 |
1610 |
Rabbit human t lymphocyte immunoglobulin |
Rabbit |
- |
- |
- |
013 [2] 13, 60 💬 |
1611 |
Radiation: gadopentetate dimeglumine |
Gadopentetic acid |
[2] D01707 D01707, D08006 D08006 💬 |
- |
- |
013 [2] 13, 34 💬 |
1612 |
Ralenova |
- |
- |
- |
- |
013 [1] 13 💬 |
1613 |
Raltegravir |
Raltegravir |
[1] D06676 D06676 💬 |
- |
- |
013 [4] 13, 26, 93, 265 💬 |
1614 |
Ramatroban |
Ramatroban |
[1] D01128 D01128 💬 |
PTGDR [2] PTGDR, TBXA2R 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
013 [1] 13 💬 |
1615 |
Ranitidine |
Ranitidine |
[2] D00422 D00422, D00673 D00673 💬 |
HRH2 [1] HRH2 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
013 [2] 13, 65 💬 |
1616 |
Raptiva |
- |
- |
- |
- |
011 [9] 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
1617 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 [7] 11, 13, 46, 53, 61, 95, 96 💬 |
1618 |
Ras |
- |
- |
- |
- |
006 [3] 6 , 13, 66 💬 |
1619 |
Ratg |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [3] 13, 51, 60 💬 |
1620 |
Ravulizumab |
Ravulizumab |
[1] D11054 D11054 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
002 [5] 2 , 11, 13, 62, 109 💬 |
1621 |
Rc18 160 mg |
- |
- |
- |
- |
013 [2] 13, 53 💬 |
1622 |
Rc18 160mg |
- |
- |
- |
- |
011 [3] 11, 13, 66 💬 |
1623 |
Rc18 240mg |
- |
- |
- |
- |
013 [2] 13, 66 💬 |
1624 |
Rebif |
- |
- |
- |
- |
013 [1] 13 💬 |
1625 |
Rebif (ifn beta-1a subcutaneous three times per week) |
- |
- |
- |
- |
013 [1] 13 💬 |
1626 |
Rebif (ifn ß-1a subcutaneous three times per week) |
- |
- |
- |
- |
013 [1] 13 💬 |
1627 |
Rebif (interferon beta 1a) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1628 |
Rebif (interferon beta-1a) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1629 |
Rebif (interferon beta-1a), merck serono europe ltd |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1630 |
Rebif 22 |
- |
- |
- |
- |
013 [1] 13 💬 |
1631 |
Rebif 22 micrograms |
- |
- |
- |
- |
013 [1] 13 💬 |
1632 |
Rebif 22 y 44 mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
1633 |
Rebif 22® |
- |
- |
- |
- |
013 [1] 13 💬 |
1634 |
Rebif 44 |
- |
- |
- |
- |
013 [1] 13 💬 |
1635 |
Rebif 44 microgramos solución inyectable |
- |
- |
- |
- |
013 [1] 13 💬 |
1636 |
Rebif 44 microgramos solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 [1] 13 💬 |
1637 |
Rebif 44 micrograms |
- |
- |
- |
- |
013 [1] 13 💬 |
1638 |
Rebif 44 micrograms solution for injection |
- |
- |
- |
- |
013 [1] 13 💬 |
1639 |
Rebif 44 micrograms solution for injection in pre-filled syringe |
- |
- |
- |
- |
013 [1] 13 💬 |
1640 |
Rebif 44 µg |
- |
- |
- |
- |
013 [1] 13 💬 |
1641 |
Rebif 44® |
- |
- |
- |
- |
013 [1] 13 💬 |
1642 |
Rebif 8,8 µg, rebif 22µg |
- |
- |
- |
- |
013 [1] 13 💬 |
1643 |
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack |
- |
- |
- |
- |
013 [1] 13 💬 |
1644 |
Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack. |
- |
- |
- |
- |
013 [1] 13 💬 |
1645 |
Rebif new formulation + ibuprofen prn |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
1646 |
Rebif new formulation + prophylactic ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
1647 |
Rebif new formulation 44mcg multidose cartridge |
- |
- |
- |
- |
013 [1] 13 💬 |
1648 |
Rebif new formulation non titrated |
- |
- |
- |
- |
013 [1] 13 💬 |
1649 |
Rebif new formulation titrated |
- |
- |
- |
- |
013 [1] 13 💬 |
1650 |
Rebif sc 12sir 12000000ui44mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
1651 |
Rebif sc 12sir 6000000ui 22mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
1652 |
Rebif*sc 12sir 12000000ui44mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
1653 |
Rebif*sc 12sir 6000000ui 22mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
1654 |
Rebif® |
- |
- |
- |
- |
013 [1] 13 💬 |
1655 |
Rebif® (clone 484-39) |
- |
- |
- |
- |
013 [1] 13 💬 |
1656 |
Rebif® new formulation |
- |
- |
- |
- |
013 [1] 13 💬 |
1657 |
Rebif® new formulation (ifn-beta-1a, rnf) |
- |
- |
- |
- |
013 [1] 13 💬 |
1658 |
Rebif® new formulation (rnf) |
- |
- |
- |
- |
013 [1] 13 💬 |
1659 |
Rebif® new formulation (rnf) using rebismarttm |
- |
- |
- |
- |
013 [1] 13 💬 |
1660 |
Recombinant human alpha b-crystallin |
- |
- |
- |
- |
013 [1] 13 💬 |
1661 |
Recombinant human erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
013 [1] 13 💬 |
1662 |
Recombinant human ifn beta |
- |
- |
- |
- |
013 [1] 13 💬 |
1663 |
Recombinant human interferon beta |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
1664 |
Recombinant humanized anti-alpha 4 integrin antibody |
- |
- |
- |
- |
013 [1] 13 💬 |
1665 |
Recombinant interferon beta-1b |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1666 |
Repository corticotropin injection |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [5] 2 , 13, 46, 84, 222 💬 |
1667 |
Revaxis |
- |
- |
- |
- |
013 [1] 13 💬 |
1668 |
Rg2077 (ctla4-igg4m) |
- |
- |
- |
- |
013 [1] 13 💬 |
1669 |
Rhb-104 |
- |
- |
- |
- |
013 [2] 13, 96 💬 |
1670 |
Rhepo |
- |
- |
- |
- |
013 [1] 13 💬 |
1671 |
Rhifn beta-1b |
- |
- |
- |
- |
013 [1] 13 💬 |
1672 |
Rhigf-1 (cep-151) |
- |
- |
- |
- |
013 [1] 13 💬 |
1673 |
Rhigm22 |
- |
- |
- |
- |
013 [1] 13 💬 |
1674 |
Rhumab 2h7 |
- |
- |
- |
- |
013 [3] 13, 46, 49 💬 |
1675 |
Rhumab to il-17a (igg1-k-class) |
- |
- |
- |
- |
013 [4] 13, 46, 56, 96 💬 |
1676 |
Rhumab to il-17a igg1-k-class |
- |
- |
- |
- |
013 [1] 13 💬 |
1677 |
Rhuph20 |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
1678 |
Riboflavin |
Riboflavin |
[3] D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
013 [8] 13, 38, 46, 96, 97, 162, 168, 265 💬 |
1679 |
Rifampin |
Rifampicin |
[1] D00211 D00211 💬 |
- |
- |
006 [5] 6 , 13, 84, 86, 299 💬 |
1680 |
Rilutek |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
1681 |
Riluzole |
Riluzole |
[1] D00775 D00775 💬 |
GRIA1 [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [8] 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
1682 |
Ritalin |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1683 |
Ritalin la 20mg capsules |
- |
- |
- |
- |
013 [1] 13 💬 |
1684 |
Ritalin la 30mg capsules |
- |
- |
- |
- |
013 [1] 13 💬 |
1685 |
Ritalin la 40mg capsules |
- |
- |
- |
- |
013 [1] 13 💬 |
1686 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
1687 |
Rituximab infusion |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [2] 13, 222 💬 |
1688 |
Rituximab it |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1689 |
Rituximab iv |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1690 |
Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1691 |
Rivastigmin |
- |
- |
- |
- |
013 [1] 13 💬 |
1692 |
Rivastigmine |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
005 [3] 5 , 6 , 13 💬 |
1693 |
Rivastigmine transdermal patch |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [2] 6 , 13 💬 |
1694 |
Rnf |
- |
- |
- |
- |
013 [1] 13 💬 |
1695 |
Rns60 |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
1696 |
Rns60 125 ml |
- |
- |
- |
- |
013 [1] 13 💬 |
1697 |
Rns60 250 ml |
- |
- |
- |
- |
013 [1] 13 💬 |
1698 |
Ro 496-4913/f03 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1699 |
Ro 496-4913/f07 |
- |
- |
- |
- |
013 [1] 13 💬 |
1700 |
Ro0506997 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1701 |
Ro4964913 |
- |
- |
- |
- |
013 [1] 13 💬 |
1702 |
Ro4964913 f07 |
- |
- |
- |
- |
013 [1] 13 💬 |
1703 |
Ro4964913/f03 |
- |
- |
- |
- |
013 [1] 13 💬 |
1704 |
Ro4964913/f07 |
- |
- |
- |
- |
013 [1] 13 💬 |
1705 |
Ro4964913/f07-01 |
- |
- |
- |
- |
013 [1] 13 💬 |
1706 |
Ro4964913/f07-01 (commercial) |
- |
- |
- |
- |
013 [1] 13 💬 |
1707 |
Ro4964913/f07-01 (development) |
- |
- |
- |
- |
013 [1] 13 💬 |
1708 |
Ro5333787 |
- |
- |
- |
- |
013 [1] 13 💬 |
1709 |
Ro7010939 |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1710 |
Rolipram |
Rolipram |
[1] D01783 D01783 💬 |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways [5] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
008 [2] 8 , 13 💬 |
1711 |
Rpc-1063 |
- |
- |
- |
- |
013 [1] 13 💬 |
1712 |
Rpc1063 |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1713 |
Rtl1000 (recombinant t cell receptor ligand) |
- |
- |
- |
- |
013 [1] 13 💬 |
1714 |
S-warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
013 [1] 13 💬 |
1715 |
Sa237 |
- |
- |
- |
- |
013 [1] 13 💬 |
1716 |
Saline |
- |
- |
- |
- |
006 [10] 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
1717 |
Sar339658 |
- |
- |
- |
- |
013 [2] 13, 97 💬 |
1718 |
Sar442168 |
- |
- |
- |
- |
013 [1] 13 💬 |
1719 |
Sativex |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
1720 |
Sativex oromucosal spray |
- |
- |
- |
- |
013 [1] 13 💬 |
1721 |
Sativex oromucosal spray (non-marketed) |
- |
- |
- |
- |
013 [1] 13 💬 |
1722 |
Sativex® |
- |
- |
- |
- |
013 [1] 13 💬 |
1723 |
Satralizumab |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1724 |
Satralizumab (120 mg/pfs with nsd) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1725 |
Satralizumab (120 mg/vial) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1726 |
Satralizumab (120mg/vial) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1727 |
Satralizumab (r-inn) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1728 |
Satralizumab (ro5333787/enspryng /sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1729 |
Satralizumab (ro5333787/enspryng/sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1730 |
Satralizumab (ro5333787/sa237) |
Satralizumab |
[1] D11079 D11079 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1731 |
Satrazlizumab (ro5333787/ enspryng /sa237) |
- |
- |
- |
- |
013 [1] 13 💬 |
1732 |
Sb-683699 |
- |
- |
- |
- |
013 [1] 13 💬 |
1733 |
Sb683699 |
- |
- |
- |
- |
013 [1] 13 💬 |
1734 |
Sc interferon beta-1a |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1735 |
Sc interferon beta-1b |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1736 |
Sc peginterferon beta-1a |
Peginterferon beta-1a |
[1] D10483 D10483 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1737 |
Sclerolym |
- |
- |
- |
- |
013 [1] 13 💬 |
1738 |
Scm |
- |
- |
- |
- |
013 [1] 13 💬 |
1739 |
Scm-010 |
- |
- |
- |
- |
013 [1] 13 💬 |
1740 |
Seasonal influenza vaccine |
- |
- |
- |
- |
013 [2] 13, 46 💬 |
1741 |
Seasonal quadrivalent influenza vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
1742 |
Second-generation fumaric acid |
Fumaric Acid |
[1] D02308 D02308 💬 |
- |
- |
013 [1] 13 💬 |
1743 |
Secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
013 [7] 13, 37, 41, 46, 160, 269, 271 💬 |
1744 |
See intervention description) |
- |
- |
- |
- |
013 [1] 13 💬 |
1745 |
Selenium |
Selenium |
- |
- |
- |
013 [3] 13, 278, 298 💬 |
1746 |
Sendoxan |
- |
- |
- |
- |
013 [2] 13, 43 💬 |
1747 |
Sendoxane |
- |
- |
- |
- |
013 [1] 13 💬 |
1748 |
Serum containing avonex |
- |
- |
- |
- |
013 [1] 13 💬 |
1749 |
Serum free avonex |
- |
- |
- |
- |
013 [1] 13 💬 |
1750 |
Sh u 555 c |
- |
- |
- |
- |
013 [1] 13 💬 |
1751 |
Silodyx |
- |
- |
- |
- |
013 [1] 13 💬 |
1752 |
Simethicone |
Simethicone |
[1] D05841 D05841 💬 |
- |
- |
013 [2] 13, 96 💬 |
1753 |
Simvahexal® 40 mg filmtabletten |
- |
- |
- |
- |
013 [1] 13 💬 |
1754 |
Simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
1755 |
Simvastatin 40 mg film-coated tablets |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1756 |
Simvastatin alternova |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1757 |
Simvastatin in relapsing remitting multiple sclerosis |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1758 |
Simvastatina |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1759 |
Simvastatina sandoz 40 mg comprimidos recubiertos con película efg |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1760 |
Simvastatine |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [3] 6 , 13, 288 💬 |
1761 |
Simvastatine sandoz 40 mg filmomhulde tabletten |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1762 |
Simvastatine sandoz 40mg deelbare filmomhulde tabletten |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1763 |
Sinvastatina sandoz 40 mg comprimidos revestidos por película |
- |
- |
- |
- |
013 [1] 13 💬 |
1764 |
Siponimod |
Siponimod |
[1] D11460 D11460 💬 |
S1PR1 [2] S1PR1, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 50 💬 |
1765 |
Siponimod 0.25 mg tablet |
Siponimod |
[1] D11460 D11460 💬 |
S1PR1 [2] S1PR1, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 50 💬 |
1766 |
Siponimod 0.5 mg tablet |
Siponimod |
[1] D11460 D11460 💬 |
S1PR1 [2] S1PR1, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 50 💬 |
1767 |
Siponimod 1 mg tablet |
Siponimod |
[1] D11460 D11460 💬 |
S1PR1 [2] S1PR1, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 50 💬 |
1768 |
Siponimod 2 mg tablet |
Siponimod |
[1] D11460 D11460 💬 |
S1PR1 [2] S1PR1, S1PR5 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 50 💬 |
1769 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
1770 |
Sivatin |
- |
- |
- |
- |
013 [1] 13 💬 |
1771 |
Sivatin 40 mg film-coated tablets |
- |
- |
- |
- |
013 [1] 13 💬 |
1772 |
Sivelestat |
Sivelestat |
[1] D03788 D03788 💬 |
ELANE [1] ELANE 💬 |
Neutrophil extracellular trap formation [3] Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer |
013 [3] 13, 85, 96 💬 |
1773 |
Smderpept |
- |
- |
- |
- |
013 [1] 13 💬 |
1774 |
Smoked cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
1775 |
Sodium chlorid |
- |
- |
- |
- |
013 [1] 13 💬 |
1776 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
1777 |
Sodium chloride solution |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
011 [3] 11, 13, 228 💬 |
1778 |
Solifenacin |
Solifenacin |
[2] D01269 D01269, D08522 D08522 💬 |
CHRM3 [1] CHRM3 💬 |
Alzheimer disease [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 [2] 6 , 13 💬 |
1779 |
Solifenacin succinate |
Solifenacin |
[2] D01269 D01269, D08522 D08522 💬 |
CHRM3 [1] CHRM3 💬 |
Alzheimer disease [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
013 [1] 13 💬 |
1780 |
Soliris |
- |
- |
- |
- |
011 [7] 11, 13, 14, 61, 62, 109, 222 💬 |
1781 |
Solu medrol - 125 mg/2 ml polvere e solvente per soluzione iniettabile 1 flacone a doppia camera da 125 mg/2 ml |
- |
- |
- |
- |
013 [3] 13, 14, 53 💬 |
1782 |
Solu-medrol |
- |
- |
- |
- |
013 [7] 13, 49, 50, 51, 53, 97, 211 💬 |
1783 |
Solu-moderin 1 g |
- |
- |
- |
- |
013 [1] 13 💬 |
1784 |
Solumedrol |
- |
- |
- |
- |
013 [1] 13 💬 |
1785 |
Solumedrol im 125mg/2ml |
- |
- |
- |
- |
013 [1] 13 💬 |
1786 |
Somatorelin |
Somatorelin |
[1] D08523 D08523 💬 |
GHRHR [1] GHRHR 💬 |
Growth hormone synthesis, secretion and action [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
013 [2] 13, 78 💬 |
1787 |
Sparc0921 |
- |
- |
- |
- |
013 [1] 13 💬 |
1788 |
Spiropent |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1789 |
Sr-fampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
1790 |
Ss-interferon |
- |
- |
- |
- |
013 [1] 13 💬 |
1791 |
Standard gadolinium contrast |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
1792 |
Standard interval dosing |
- |
- |
- |
- |
013 [1] 13 💬 |
1793 |
Standard ms dmt |
- |
- |
- |
- |
013 [1] 13 💬 |
1794 |
Standard ms dmts |
- |
- |
- |
- |
013 [1] 13 💬 |
1795 |
Standard of care |
- |
- |
- |
- |
006 [12] 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
1796 |
Standard treatment with a conventional drug |
- |
- |
- |
- |
013 [1] 13 💬 |
1797 |
Standardized cannabis extract |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
1798 |
Statin |
- |
- |
- |
- |
013 [1] 13 💬 |
1799 |
Stem cell transplantation |
- |
- |
- |
- |
013 [10] 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬 |
1800 |
Study drug |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1801 |
Sub0750mig |
- |
- |
- |
- |
013 [1] 13 💬 |
1802 |
Sub175614 |
- |
- |
- |
- |
013 [1] 13 💬 |
1803 |
Sub22282 |
- |
- |
- |
- |
013 [1] 13 💬 |
1804 |
Sublingual tizanidine 12 mg |
Tizanidine |
[2] D00776 D00776, D08611 D08611 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1805 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
1806 |
Sunphenon |
- |
- |
- |
- |
013 [2] 13, 113 💬 |
1807 |
Sunphenon egcg |
Epigallocatechin gallate |
- |
- |
- |
013 [3] 13, 17, 113 💬 |
1808 |
Sunphenon egcg tm |
- |
- |
- |
- |
013 [1] 13 💬 |
1809 |
Suspension media |
- |
- |
- |
- |
013 [1] 13 💬 |
1810 |
Sustained-release oral dalfampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [1] 13 💬 |
1811 |
Suvorexant |
Suvorexant |
[1] D10082 D10082 💬 |
HCRTR1 [2] HCRTR1, HCRTR2 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
005 [3] 5 , 6 , 13 💬 |
1812 |
T cell vaccination |
- |
- |
- |
- |
013 [1] 13 💬 |
1813 |
T-cell vaccination |
- |
- |
- |
- |
013 [1] 13 💬 |
1814 |
Tachipirina |
- |
- |
- |
- |
013 [2] 13, 53 💬 |
1815 |
Tachipirina - 500 mg compresse20 compresse |
- |
- |
- |
- |
013 [2] 13, 53 💬 |
1816 |
Taci-fc5 |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [3] 13, 46, 49 💬 |
1817 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
1818 |
Tanakan |
Ginkgo biloba |
- |
- |
- |
013 [1] 13 💬 |
1819 |
Tarenflurbil |
Tarenflurbil |
[1] D09010 D09010 💬 |
APH1A [4] APH1A, NCSTN, PSEN1, PSENEN 💬 |
Alzheimer disease [6] Alzheimer disease, Human papillomavirus infection, Neurotrophin signaling pathway, Notch signaling pathway, Pathways of neurodegeneration - multiple diseases, Wnt signaling pathway |
013 [1] 13 💬 |
1820 |
Targretin |
- |
- |
- |
- |
013 [1] 13 💬 |
1821 |
Taurine |
Taurine |
[1] D00047 D00047 💬 |
- |
- |
013 [1] 13 💬 |
1822 |
Tauroursodeoxycholic acid |
Tauroursodeoxycholic acid |
[1] D11836 D11836 💬 |
- |
- |
002 [4] 2 , 13, 93, 299 💬 |
1823 |
Tcelna |
- |
- |
- |
- |
013 [1] 13 💬 |
1824 |
Tecfidera |
- |
- |
- |
- |
013 [1] 13 💬 |
1825 |
Tecfidera (bg00012) |
- |
- |
- |
- |
013 [1] 13 💬 |
1826 |
Tecfidera (bg12) |
- |
- |
- |
- |
013 [1] 13 💬 |
1827 |
Tecfidera® |
- |
- |
- |
- |
013 [1] 13 💬 |
1828 |
Tecfidera® 120 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1829 |
Tecfidera® 120mg magensaftresistente hartkapseln |
- |
- |
- |
- |
013 [1] 13 💬 |
1830 |
Tecfidera® 240 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1831 |
Tecfidera® 240mg magensaftresistente hartkapseln |
- |
- |
- |
- |
013 [1] 13 💬 |
1832 |
Tecifdera (dimethyl fumarate) |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [1] 13 💬 |
1833 |
Temelimab |
Temelimab |
- |
- |
- |
013 [1] 13 💬 |
1834 |
Temelimab 18 mg/kg |
Temelimab |
- |
- |
- |
013 [1] 13 💬 |
1835 |
Temelimab 36 mg/kg |
Temelimab |
- |
- |
- |
013 [1] 13 💬 |
1836 |
Temelimab 54 mg/kg |
Temelimab |
- |
- |
- |
013 [1] 13 💬 |
1837 |
Temsirolimus |
Temsirolimus |
[1] D06068 D06068 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
013 [4] 13, 34, 89, 331 💬 |
1838 |
Temsirolimus tablets |
Temsirolimus |
[1] D06068 D06068 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
013 [1] 13 💬 |
1839 |
Teriflunomide |
Teriflunomide |
[1] D10172 D10172 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 [2] 13, 25 💬 |
1840 |
Teriflunomide (hmr1726) |
Teriflunomide |
[1] D10172 D10172 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 [1] 13 💬 |
1841 |
Teriflunomide 14 mg |
Teriflunomide |
[1] D10172 D10172 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 [1] 13 💬 |
1842 |
Teriflunomide 14 mg oral tablet [aubagio] |
Teriflunomide |
[1] D10172 D10172 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 [1] 13 💬 |
1843 |
Teriflunomide capsule |
Teriflunomide |
[1] D10172 D10172 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 [1] 13 💬 |
1844 |
Teriflunomide hmr1726 |
Teriflunomide |
[1] D10172 D10172 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 [1] 13 💬 |
1845 |
Testosterone |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 [8] 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
1846 |
Testosterone undecanoate |
Testosterone |
[6] D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 [2] 13, 60 💬 |
1847 |
Tetanus diphtheria toxoid vaccine (td) |
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [1] 13 💬 |
1848 |
Tetanus diphtheria toxoids vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
1849 |
Tetanus toxoid |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [2] 13, 46 💬 |
1850 |
Tetanus toxoid (tt) containing vaccine (td, tdap) |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [1] 13 💬 |
1851 |
Tetanus toxoid vaccine |
Clostridium tetani toxoid antigen (formaldehyde inactivated) |
- |
- |
- |
013 [1] 13 💬 |
1852 |
Tetracycline |
Tetracycline |
[1] D00201 D00201 💬 |
- |
- |
013 [4] 13, 46, 53, 97 💬 |
1853 |
Tetracycline - statin - antimycotic |
Tetracycline |
[1] D00201 D00201 💬 |
- |
- |
013 [1] 13 💬 |
1854 |
Tetrahydrocannabinol |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 [3] 8 , 13, 298 💬 |
1855 |
Tetrahydrocannabinol botanical drug substance (thc bds) |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
1856 |
Tg |
- |
- |
- |
- |
013 [2] 13, 37 💬 |
1857 |
Tg-1101 |
- |
- |
- |
- |
013 [1] 13 💬 |
1858 |
Thc |
- |
- |
- |
- |
008 [4] 8 , 13, 46, 96 💬 |
1859 |
Thiamine |
Thiamine |
[1] D08580 D08580 💬 |
- |
- |
008 [3] 8 , 13, 265 💬 |
1860 |
Thioplex |
- |
- |
- |
- |
013 [1] 13 💬 |
1861 |
Thiotepa |
Thiotepa |
[1] D00583 D00583 💬 |
- |
- |
013 [11] 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
1862 |
Thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [5] 13, 36, 51, 60, 96 💬 |
1863 |
Thymoglobuline® |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [1] 13 💬 |
1864 |
Tissue selective estrogen complex |
- |
- |
- |
- |
013 [1] 13 💬 |
1865 |
Tizanidine |
Tizanidine |
[2] D00776 D00776, D08611 D08611 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1866 |
Tizanidine (sublingual or oral) |
Tizanidine |
[2] D00776 D00776, D08611 D08611 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1867 |
Tizanidine hydrochloride capsule |
Tizanidine |
[2] D00776 D00776, D08611 D08611 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1868 |
Tmp001 |
- |
- |
- |
- |
013 [1] 13 💬 |
1869 |
Tocilizumab |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 [18] 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
1870 |
Tocilizumab injection |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
1871 |
Tocopherol |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
013 [5] 13, 49, 206, 257, 298 💬 |
1872 |
Tolerogenic dendritic cells (toldc) |
- |
- |
- |
- |
013 [1] 13 💬 |
1873 |
Tolerogenic dendritic cells loaded with myelin peptides |
- |
- |
- |
- |
013 [1] 13 💬 |
1874 |
Tolperisone |
Tolperisone |
[1] D08617 D08617 💬 |
- |
- |
013 [1] 13 💬 |
1875 |
Tolperisone hc1 |
Tolperisone |
[1] D08617 D08617 💬 |
- |
- |
013 [1] 13 💬 |
1876 |
Tolperisone hcl |
Tolperisone |
[1] D08617 D08617 💬 |
- |
- |
013 [1] 13 💬 |
1877 |
Tolpersan |
- |
- |
- |
- |
013 [1] 13 💬 |
1878 |
Tolposan |
- |
- |
- |
- |
013 [1] 13 💬 |
1879 |
Topical preparation h arm |
- |
- |
- |
- |
013 [1] 13 💬 |
1880 |
Torvast |
- |
- |
- |
- |
013 [1] 13 💬 |
1881 |
Torvast*10cpr 10mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1882 |
Tovaxin |
- |
- |
- |
- |
013 [1] 13 💬 |
1883 |
Tovaxin autologous t cell vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
1884 |
Tracleer |
- |
- |
- |
- |
013 [8] 13, 51, 84, 85, 86, 88, 210, 211 💬 |
1885 |
Trancopal |
- |
- |
- |
- |
013 [1] 13 💬 |
1886 |
Trancopal dolo |
- |
- |
- |
- |
013 [1] 13 💬 |
1887 |
Treosulfan |
Treosulfan |
[1] D07253 D07253 💬 |
- |
- |
013 [3] 13, 19, 65 💬 |
1888 |
Trichuris suis eggs |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1889 |
Trichuris suis ova |
- |
- |
- |
- |
013 [4] 13, 46, 96, 97 💬 |
1890 |
Trichuris suis ova (eggs), embryonated, viable |
- |
- |
- |
- |
013 [1] 13 💬 |
1891 |
Trileptal |
- |
- |
- |
- |
013 [1] 13 💬 |
1892 |
Triomar™ (omega-3 fatty acids) |
Omega-3 fatty acids |
- |
- |
- |
013 [1] 13 💬 |
1893 |
Trivalent seasonal influenza vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
1894 |
Tro19622 |
TRO19622 |
- |
- |
- |
002 [3] 2 , 3 , 13 💬 |
1895 |
Trulicity |
- |
- |
- |
- |
013 [1] 13 💬 |
1896 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere |
- |
- |
- |
- |
013 [1] 13 💬 |
1897 |
Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere. |
- |
- |
- |
- |
013 [1] 13 💬 |
1898 |
Tso |
- |
- |
- |
- |
013 [3] 13, 46, 97 💬 |
1899 |
Tt vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
1900 |
Tv-5010 |
- |
- |
- |
- |
013 [1] 13 💬 |
1901 |
Tv-5600 |
- |
- |
- |
- |
008 [3] 8 , 13, 96 💬 |
1902 |
Tylenol pill |
- |
- |
- |
- |
013 [1] 13 💬 |
1903 |
Tysabri |
- |
- |
- |
- |
013 [3] 13, 25, 63 💬 |
1904 |
Tysabri 300 mg concentrado para solución para perfusión |
- |
- |
- |
- |
013 [1] 13 💬 |
1905 |
Tysabri 300 mg concentrate for solution for infusion |
- |
- |
- |
- |
013 [1] 13 💬 |
1906 |
Tysabri 300 mg solution à diluer pour perfusion |
- |
- |
- |
- |
013 [1] 13 💬 |
1907 |
Tysabri and avonex |
- |
- |
- |
- |
013 [1] 13 💬 |
1908 |
Tysabri ® (natalizumab) |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1909 |
Tysabri*iv 1fl 300mg 15ml |
- |
- |
- |
- |
013 [1] 13 💬 |
1910 |
Tysabri® |
- |
- |
- |
- |
013 [1] 13 💬 |
1911 |
Tysabri® (natalizumab) |
Natalizumab |
[1] D06886 D06886 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
1912 |
Ublituximab |
Ublituximab |
[1] D11243 D11243 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
1913 |
Ubltuximab |
- |
- |
- |
- |
013 [1] 13 💬 |
1914 |
Ucb l059 |
- |
- |
- |
- |
013 [1] 13 💬 |
1915 |
Uk: sativex oromucosal spray |
- |
- |
- |
- |
013 [1] 13 💬 |
1916 |
Ultomiris |
- |
- |
- |
- |
002 [4] 2 , 11, 13, 62 💬 |
1917 |
Ultra small particles of iron oxide (uspio) |
Ferric oxide |
[1] D04168 D04168 💬 |
- |
- |
013 [1] 13 💬 |
1918 |
Ultrasmall particles of iron oxide |
Ferric oxide |
[1] D04168 D04168 💬 |
- |
- |
013 [1] 13 💬 |
1919 |
Umbilical cord derived mesenchymal stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
1920 |
Umbilical cord mesenchymal stem cells |
- |
- |
- |
- |
013 [5] 13, 46, 57, 97, 113 💬 |
1921 |
Undifferentiated autologous mesenchymal stem cells |
- |
- |
- |
- |
013 [1] 13 💬 |
1922 |
Untreated to atorvastatin treatment |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
1923 |
Urbason |
- |
- |
- |
- |
013 [3] 13, 97, 222 💬 |
1924 |
Urbason 40 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1925 |
Urbason 40 mg comprimidos |
- |
- |
- |
- |
013 [1] 13 💬 |
1926 |
Urbason forte |
- |
- |
- |
- |
013 [1] 13 💬 |
1927 |
Urbason solubile forte 1000mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1928 |
Urbason® solubile forte 1000 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1929 |
Urine samples |
- |
- |
- |
- |
013 [1] 13 💬 |
1930 |
Uvedose 100 000 ui |
- |
- |
- |
- |
013 [1] 13 💬 |
1931 |
Uvedose 100 000 ui, solution buvable en ampoule |
- |
- |
- |
- |
013 [1] 13 💬 |
1932 |
V08ca02 |
- |
- |
- |
- |
013 [1] 13 💬 |
1933 |
V08ca09 |
- |
- |
- |
- |
013 [1] 13 💬 |
1934 |
Vaginal estriol |
Estriol |
[2] D00185 D00185, D01986 D01986 💬 |
ESR1 [2] ESR1, ESR2 💬 |
Breast cancer [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
013 [1] 13 💬 |
1935 |
Vardenafil |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [3] 13, 86, 299 💬 |
1936 |
Vardenafil (hidrocloride) |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1937 |
Vardenafilo |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1938 |
Vardenafilo hidrocloruro |
Vardenafil |
[3] D02731 D02731, D03260 D03260, D08668 D08668 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
1939 |
Vatelizumab |
Vatelizumab |
- |
- |
- |
013 [2] 13, 97 💬 |
1940 |
Vay736 |
- |
- |
- |
- |
013 [7] 13, 35, 46, 49, 53, 85, 95 💬 |
1941 |
Vb13s1 |
- |
- |
- |
- |
013 [1] 13 💬 |
1942 |
Vb5s2 |
- |
- |
- |
- |
013 [1] 13 💬 |
1943 |
Vb6s5 |
- |
- |
- |
- |
013 [1] 13 💬 |
1944 |
Vehicle gel |
- |
- |
- |
- |
013 [2] 13, 34 💬 |
1945 |
Venlafaxin hexal |
- |
- |
- |
- |
013 [1] 13 💬 |
1946 |
Venlafaxine |
Venlafaxine |
[2] D00821 D00821, D08670 D08670 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [3] 6 , 13, 46 💬 |
1947 |
Venlafaxine hydrochloride |
Venlafaxine |
[2] D00821 D00821, D08670 D08670 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [2] 13, 46 💬 |
1948 |
Verum arm receiving gilenya® |
- |
- |
- |
- |
013 [1] 13 💬 |
1949 |
Verum arm receiving vitamin d oil |
Vitamin D |
- |
- |
- |
013 [1] 13 💬 |
1950 |
Vessel |
- |
- |
- |
- |
013 [4] 13, 51, 271, 288 💬 |
1951 |
Vidofludimus |
Vidofludimus |
- |
- |
- |
013 [5] 13, 46, 94, 96, 97 💬 |
1952 |
Vidofludimus calcium |
Calcium |
- |
- |
- |
013 [4] 13, 94, 96, 97 💬 |
1953 |
Vigantol |
- |
- |
- |
- |
013 [4] 13, 65, 96, 97 💬 |
1954 |
Vigantol oel |
- |
- |
- |
- |
013 [3] 13, 96, 97 💬 |
1955 |
Vigantol oil |
- |
- |
- |
- |
013 [1] 13 💬 |
1956 |
Vigantol oil plus interferon beta-1a (rebif) |
Human interferon beta |
[1] D04554 D04554 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
1957 |
Vigantol® oil |
- |
- |
- |
- |
013 [1] 13 💬 |
1958 |
Vigantol® öl 20.000 i.e./ml |
- |
- |
- |
- |
013 [1] 13 💬 |
1959 |
Vitamin a |
Vitamin A |
[2] D00069 D00069, D06543 D06543 💬 |
RARA [2] RARA, RARB 💬 |
Acute myeloid leukemia [8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
013 [3] 13, 53, 90 💬 |
1960 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 [21] 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
1961 |
Vitamin d3 |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 [11] 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
1962 |
Vitamin e |
Vitamin E |
[1] D02331 D02331 💬 |
- |
- |
002 [11] 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
1963 |
Vitamin e/selenium |
Selenium |
[1] D02331 D02331 💬 |
- |
- |
013 [1] 13 💬 |
1964 |
Vitamin k |
Phylloquinone |
[1] D00148 D00148 💬 |
- |
- |
013 [5] 13, 46, 96, 97, 299 💬 |
1965 |
Vitamina d3 kern pharma solución oleosa |
- |
- |
- |
- |
013 [1] 13 💬 |
1966 |
Vsn16r |
- |
- |
- |
- |
013 [1] 13 💬 |
1967 |
Vsn16r 100mg |
- |
- |
- |
- |
013 [1] 13 💬 |
1968 |
Vx15/2503 |
- |
- |
- |
- |
008 [2] 8 , 13 💬 |
1969 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
1970 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
1971 |
Way-130799 |
- |
- |
- |
- |
013 [1] 13 💬 |
1972 |
Xbd173 |
- |
- |
- |
- |
013 [1] 13 💬 |
1973 |
Xcel-mc-alpha |
- |
- |
- |
- |
013 [1] 13 💬 |
1974 |
Xeomin |
- |
- |
- |
- |
005 [7] 5 , 6 , 7 , 13, 15, 17, 113 💬 |
1975 |
Xyosted |
- |
- |
- |
- |
013 [1] 13 💬 |
1976 |
Xyosted 75 milligram (mg) in 0.5 ml auto-injector |
- |
- |
- |
- |
013 [1] 13 💬 |
1977 |
Zenapax |
- |
- |
- |
- |
013 [1] 13 💬 |
1978 |
Zinbryta |
- |
- |
- |
- |
013 [1] 13 💬 |
1979 |
Zk 157046 |
- |
- |
- |
- |
013 [1] 13 💬 |
1980 |
Zol446h |
- |
- |
- |
- |
013 [1] 13 💬 |
1981 |
Zoledronic acid |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [9] 6 , 13, 46, 93, 95, 96, 274, 299, 333 💬 |
1982 |
Zoledronic acid monohydrate |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |